Key points
-
•
The development of the kidney depends on the triadic interactions among three types of progenitors: the nephron progenitor, the ureteric bud, and the stromal progenitor.
-
•
The epithelial cells that comprise the tubular structures of the kidney are derived from two distinct progenitors: the ureteric bud, which branches and gives rise to collecting ducts, and the nephron progenitor, which undergoes a mesenchyme-to-epithelial transition to form glomerular podocytes, parietal epithelial cells, proximal tubules, loops of Henle, distal tubules, and connecting tubules.
-
•
Nephrogenesis and nephron endowment require a balance between self-renewal of nephron progenitors and epithelial differentiation.
-
•
The timing of incorporation of nephron progenitors into nascent nephrons predicts their positional identity within the highly patterned mature nephron.
-
•
Collecting duct epithelia differentiate into principal cells and intercalated cells through lateral inhibition mediated by Notch signaling.
-
•
Stromal cells regulate ureteric branching morphogenesis, nephrogenesis, and vascular development.
-
•
Endothelial cells track the development of the ureteric epithelium and establish the renal vasculature through a combination of vasculogenic and angiogenic processes.
-
•
Single-cell RNA sequencing has identified representative marker genes and developmental trajectories of multiple cell types, not only in mouse kidneys but also in human kidneys.
-
•
Identification of the origins of the renal progenitors enabled generation of kidney organoids, and single-cell RNA-sequencing revealed similarities and differences between the organoids and the embryonic kidney in vivo.
Mammalian Kidney Development
Anatomic Overview of the Mammalian Kidney
The kidney is a sophisticated, highly vascularized organ that plays a central role in overall body homeostasis. In humans, the kidneys filter as much as 180 liters of blood per day, receiving as much as ∼20% of the total cardiac output. Renal filtration of blood removes metabolic waste products (e.g., urea, ammonia, and byproducts of bile from the liver) as urine while concomitantly adjusting the levels of water, electrolytes, and pH of tissue fluids. Additionally, the kidneys regulate blood pressure via the renin-angiotensin-aldosterone system; secrete erythropoietin, which stimulates erythrocyte production; and contribute to the activation of vitamin D to control calcium and phosphate balance.
The filtration function of the kidneys is accomplished by basic units called nephrons, which consist of glomeruli and renal tubules ( Fig. 1.1 ). On average, humans have 1 million nephrons per adult kidney, but the range of total nephrons is highly variable across human populations (200,000∼2.5 million). Each mouse kidney may contain up to 12,000–16,000 nephrons depending on the strain. This wide range in nephron number is influenced by genetic background, fetal nutrition and environment, and maturity at birth. , Nephron endowment can be clinically important as markedly reduced nephron numbers raise the susceptibility risk to hypertension and chronic kidney disease. At the core of the nephron is the renal corpuscle or glomerulus (see Fig. 1.1 ). The glomerulus consists of a porous and highly convoluted capillary bed composed of fenestrated glomerular endothelial cells. These glomerular capillaries are circumscribed by morphologically elaborate and interdigitating cells called podocytes. These capillaries are further structurally supported by pericytes called mesangial cells. Blood filtration occurs through this capillary tuft, generating primary urine that collects within the Bowman capsule, an enclosure formed by parietal epithelial cells. From the Bowman capsule, urine drains through a series of tubules starting with the proximal tubules, the loop of Henle, the distal tubules, and finally the collecting ducts, the latter of which is not included in the definition of a nephron. These renal tubules, as well as collecting ducts, are responsible for dynamic resorption and secretion processes that help recycle filtered small molecules; they also adjust water, electrolyte, and acid-base balance by fine-tuning the composition of the final urine output before it exits the ureter and is excreted via the bladder. Supporting the main functions of the nephrons are interstitial fibroblasts and a heterogenous network of extraglomerular vasculature.
Anatomic organization of the kidney.
(A) Spatial distribution of nephron within the metanephric kidney. Glomeruli, the filtration compartments of the nephrons, are found in the cortex. (B) Segmental structure of nephrons. The vascularized glomerulus is found at the proximal end and is connected through a series of renal tubules where urinary filtrate composition is refined through resorption and secretion. (C) Cellular organization of the glomeruli. AA, Afferent arteriole; BS, Bowman space; CD, collecting duct; DT, distal tubule; EA, efferent arteriole; GEC, glomerular endothelial cell; LOH, loop of Henle; MC, mesangial cell; PEC, parietal epithelial cell; Pod, podocyte; PT, proximal tubule.
Reproduced with permission from Scott RP, Quaggin SE. The cell biology of renal filtration. J Cell Biol. 2015;209:100–210.
Developmental Origin of the Kidney
The vertebrate kidney derives from the intermediate mesoderm (IM), which represents an anatomically defined region along the dorsoventral axis—positioned between the paraxial mesoderm, forming the somites in the dorsal part of the embryo, and the lateral plate mesoderm, which differentiates into ventrally located skeletomuscular and vascular tissues. Mammalian kidneys develop in three successive stages, generating three distinct excretory structures known as the pronephros, mesonephros, and metanephros ( Fig. 1.2 ). The pronephros and mesonephros are vestigial structures in mammals and degenerate before birth; the metanephros is the definitive mammalian kidney. Many of the signaling pathways and genes that play important roles in the metanephric kidney appear to play parallel roles during the development of the pronephros and mesonephros. The pronephros consists of pronephric tubules and the pronephric duct (also known as the precursor to the Wolffian duct) and develops from the rostral-most region of the urogenital ridge at 22 days’ gestation in humans and 8.5 days post coitum (embryonic stage E8.5) in mice ( Table 1.1 ). Throughout the rest of this chapter, most timelines of kidney development are with reference to the mouse. The pronephros serves as the principal excretory organ of the larval stages of fishes and amphibians. The mesonephros develops caudal to the pronephric tubules in the midsection of the urogenital ridge. The mesonephros becomes the functional excretory apparatus in lower vertebrates (adult fish and amphibians) and may perform a filtering function during embryonic life in mammals. Before its degeneration, endothelial, peritubular myoid, and steroidogenic cells from the mesonephros migrate into the adjacent adrenogonadal primordia, which ultimately form the adrenal gland and gonads. Abnormal mesonephric migration leads to gonadal dysgenesis, a fact that underscores the intricate association between these organ systems during development and explains the common association of gonadal and renal defects in congenital syndromes. ,
Three types of kidney primordia during mammalian development.
Schematic of mouse E11.5 embryo. The pronephros and mesonephros develop in a rostral-to-caudal direction, and the tubules are aligned adjacent to the Wolffian or nephric duct (WD) . The metanephros develops by interaction of the ureteric bud epithelium (UB), outgrowth from the caudal end of the WD, and metanephric mesenchyme (MM) . The pronephros and mesonephros are vestigial structures in mice and humans and are regressed during development.
Table 1.1
Timelines of Human and Mouse Kidney Development
| Stage/Event | Human a | Mouse b |
|---|---|---|
| Pronephros | ||
|
Emergence
Disappearance by |
22nd day
25th day |
E8.5
E10 |
| Mesonephros | ||
|
Emergence
Disappearance by |
24th day
16th week |
E10
E14 |
| Metanephros | ||
|
Ureteric bud induction
Nephrogenesis Glomerulogenesis Cessation of nephrogenesis |
28th–32nd day
44th day 8th–9th week 36th week |
E10.5
E13 E14 P3 |
| Gestation (Total Length) | 40 weeks | 19–21 days |
Development of the Metanephros from the Three Types of Progenitors
The metanephros, which is formed at the caudal end of the urogenital ridge, is the third and final kidney stage, representing the definitive adult kidney of higher vertebrates. The metanephros development relies on triad interactions among the three types of progenitors: the nephron progenitor (NP) and stromal progenitor that reside in the metanephric mesenchyme (MM) and the ureteric bud (UB) , (see Fig. 1.2 ). The NP in the MM forms the nephron (i.e., glomerular podocytes, parietal epithelial cells, proximal tubules, loops of Henle, distal tubules, and connecting tubules), while the UB gives rise to collecting ducts and the ureter. The stromal progenitor in the MM differentiates into cortical and medullary interstitial cells, as well as mesangial cells and renin-producing cells. The UB is first visible as an outgrowth at the caudal end of the Wolffian duct approximately between the fourth and fifth weeks of gestation in humans or E10.5 in mice. The MM becomes histologically distinct from the surrounding mesenchyme and is found adjacent to the UB. Upon invasion of the UB into the MM, signals from the MM cause the UB to branch into a T-shaped form (at around E11.5 in mice) and then undergo iterative dichotomous branching, giving rise to the urinary collecting duct system ( Fig. 1.3 ). Simultaneously, the UB sends reciprocal signals to NPs in the MM, which are induced to condense along the surface of the UB tips.
Ureteric branching morphogenesis.
Rapid reiterative branching of the ureteric bud epithelium within a 5-day period in mice as imaged with a pan-cytokeratin antibody using optical projection tomography. By E16.5, the renal pelvis, formed by the widening and coalescence of the earliest branches of the ureteric tree, is already apparent.
Reproduced with permission from Short KM, Smuth I. Imaging, analyzing and interpreting branching morphogenesis in the developing kidney. Results Probl Cell Differ. 2017;60:233–256.
Nephron Differentiation from the Nephron Progenitor
After condensation, a subset of NP aggregates adjacent to and below the tips of the branching UB. These cell clusters, known as pretubular aggregates, undergo mesenchymal-to-epithelial conversion to become the renal vesicle ( Fig. 1.4 ).
Overview of nephrogenesis.
Reciprocal interaction among the nephron progenitor, stromal progenitor, and ureteric bud within the nephrogenic zone enables continuous branching of the ureteric epithelium, self-renewal of nephron progenitor, and differentiation into epithelialized nephron structures. Successive proximo-distal patterning within the nascent nephron structure results in the formation of an S-shaped body with distinct gene expression patterning coding for the future nephron domains. CSB, comma-shaped body; PA, pretubular aggregate; RV, renal vesicle; SSB, S-shaped body.
The renal vesicle undergoes patterned segmentation and proceeds through a series of morphologic changes that include gradual recruitment of NPs to form the glomerulus and components of the nephrogenic tubules from the proximal convoluted tubule, loop of Henle, and distal tubule. The renal vesicles undergo differentiation, passing through morphologically distinct stages starting from the comma-shaped stage and proceeding to the S-shaped body, capillary loop, and mature stages. Each step involves precise proximal-to-distal patterning and structural transformations, ultimately forming the glomerulus and components of the nephrogenic tubules from the proximal tubule, loop of Henle, and distal tubule (see Fig. 1.4 ). Remarkably, this process is repeated 600,000 to 1 million times in each developing human kidney as new nephrons are sequentially born at the tips of the UB, namely the nephrogenic zone, throughout fetal life.
The Nephrogenic Zone
The nephrogenic zone is an active site of nephrogenesis. It is morphologically identified as a narrow band beneath the renal capsule where the branching UB tips are found together with nascent nephrons (pretubular aggregates, renal vesicles, comma-shaped bodies, and S-shaped bodies), self-renewing NPs, and stromal progenitors (see Fig. 1.4 ). Kidney growth and nephrogenesis occur in a radial fashion, with new branches of the ureteric tree and newer nephrons added at the outermost periphery of the developing cortex. Accordingly, within the developing kidney, the most mature nephrons are found in the innermost layers of the cortex and the most immature nephrons are found in the most peripheral regions (see Fig 1.1 ). The nephrogenic zone becomes progressively thinner with the gradual depletion of nephrogenic progenitors and disappears when the remaining NPs have completely epithelialized by 36 weeks’ gestation in humans and postnatal day 3 (P3) in mice. The kidney eventually divides into two major compartments: an outer region called the cortex and an inner region called the medulla. The glomeruli and proximal and distal tubules are in the cortex, along with the distal part of the nephron, which connects directly to the collecting ducts. The loop of Henle and rest of the collecting duct network comprise the epithelial structures found in the medulla.
Nephron Segment Patterning Along the Proximal–Distal Axis
The glomerulus develops from the most proximal end of the renal vesicle, farthest from the tip of the UB. , Distinct cell types of the glomerulus are first identified in the S-shaped stage, where presumptive podocytes appear as a columnar epithelial cell layer (see Fig. 1.4 ). Parietal epithelial cells differentiate and flatten to form the Bowman capsule, a structure that surrounds the urinary space and is continuous with the proximal tubular epithelium. A vascular cleft develops, separating the presumptive podocyte layer from more distal cells that will form the proximal tubule. Simultaneously, endothelial cells migrate into the cleft to form capillary loops. The tubular portion of the nephron is segmented in a proximal-distal order into the proximal convoluted tubule, descending and ascending loops of Henle, and distal convoluted tubule. The distal tubule is adjacent to the collecting duct, a derivative of the UB.
Although all segments of the nephron are present at birth and filtration occurs before birth, maturation of the tubule continues in the postnatal period. Increased expression levels of transporters, switches in transporter isoforms, alterations in paracellular transport mechanisms, and permeability and biophysical properties of tubular membranes have all been observed to occur postnatally.
Glomerulogenesis by the Interaction of Podocytes, Endothelial Cells, and Mesangial Cells
During glomerulogenesis, endothelial cells produce the glomerular basement membrane together with podocytes, a major component of the mature filtration barrier. Initially the podocytes are connected by intercellular tight junctions at their apical surface. As glomerulogenesis proceeds, the podocytes flatten and spread out to cover the increased surface area of the growing glomerular capillary bed. They develop microtubular-based primary processes and actin-based secondary foot processes. Foot processes of neighboring podocytes interdigitate and elongate. As podocytes mature, intercellular epithelial tight junctions linking become restricted to the basal aspect of the podocyte, relocate from the cell body to the foot processes and are eventually replaced by a modified adherens junction-like structure known as the slit diaphragm. , Slit diaphragms are signaling hubs serving as the final layer of the glomerular filtration barrier. Mesangial cell ingrowth follows the migration of endothelial cells and is required for development and patterning of the capillary loops that are found in normal glomeruli. The endothelial cells also flatten considerably, and capillary lumens are formed due to apoptosis of a subset of endothelial cells. At the capillary loop stage, glomerular endothelial cells develop fenestrae, which are semipermeable transcellular pores common in capillary beds exposed to high hemodynamic flux.
In the mature-stage glomerulus, the podocytes, fenestrated endothelial cells, and intervening glomerular basement membrane comprise the filtration barrier that separates the urinary from the blood space. Together, these components provide a size- and charge-selective barrier that permits free passage of small solutes and water but prevents the loss of larger molecules such as proteins. The mesangial cells are found between the capillary loops, where they are required to provide ongoing structural support to the capillaries and possess smooth muscle cell–like characteristics that have the capacity to contract, which may account for some of the dynamic properties of the glomerulus.
Collecting Duct Differentiation from the Ureteric Bud
The collecting duct system is composed of hundreds of tubules through which the filtrate produced by the nephrons is conducted out of the kidney, to the ureter, and then to the bladder. Water and salt resorption and excretion, ammonia transport, and H + ion secretion required for acid-base homeostasis also occur in the collecting ducts, under different regulatory mechanisms and using different transporters and channels that are active along tubular portions of the nephron. The collecting ducts are the product of branching morphogenesis from the single UB, which enables the formation of arborized structure with a single exit (see Fig. 1.3 ). Considerable remodeling is involved in forming collecting ducts from branches of the UB. The branching is highly patterned, with the first several rounds of branching being somewhat symmetric, followed by additional rounds of asymmetric branching, in which a main trunk of the collecting duct continues to extend toward the nephrogenic zone, while smaller buds branch as they induce new nephrons within the nephrogenic zone. The mouse kidney has a single papilla and calyx, whereas a human kidney has 8 to 10 papillae, each of which drains into a minor calyx, with several minor calyces draining into a smaller number of major calyces.
Interstitial Differentiation from the Stromal Progenitor
For decades in classic embryologic studies of kidney development, emphasis has been placed on the reciprocal inductive signals between MM and UB. However, in recent years, interest in the stromal cell as a key regulator of nephrogenesis has arisen. , The stromal progenitor in the MM differentiates into cortical and medullary interstitial cells, as well as mesangial cells and renin-producing cells ( Fig. 1.5 ). The stromal progenitor cells also provide signals required for UB branching and patterning of the developing kidney. Disruption or loss of these stromal cells leads to impairment of UB branching, reduction in nephron number, disrupted nephron patterning with failure of cortical-medullary boundary formation, and maldevelopment of the renal vasculature. A reciprocal signaling loop from the UB exists to properly pattern stromal cell populations. Loss of these UB-derived signals leads to a buildup of stromal cells beneath the capsule that are several layers thick. As nephrogenesis proceeds, stromal cells differentiate into peritubular interstitial cells and pericytes that are required for vascular remodeling and the production of extracellular matrix responsible for proper nephron formation.
The nephron and stromal progenitors.
Lineage tracing analysis in E14.5 mouse kidneys showing derivatives of Six2 -expressing nephron progenitors (A, C, and E) and the Foxd1 -expressing stromal progenitors (B, D, and F), stained for β-galactosidase activity (blue). a, Adrenal gland; cd, collecting duct; ci, renal cortical interstitium; cm, cap mesenchyme; cs, renal cortical stroma; gal, galactosidase; gc, glomerular capillary; k, kidney; mi, renal medullary interstitium; ms, mesangium; nt, nephrogenic tubule; pe, parietal epithelium; rv, renal vesicle; sb, S-shaped body; ue, ureter epithelium; um, ureter mesenchyme; ut, ureteric tip; ve, visceral epithelium (podocyte).
Reproduced with permission from Kobayashi A, Mugford JW, Krautzberger Am, et al. Identification of a multipotent self-renewing stromal progenitor population during mammalian kidney organogenesis. Stem Cell Reports . 2014;3:650–662.
Development of the Renal Vasculature
The microcirculations of the kidney include the specialized glomerular capillary system, responsible for production of the ultrafiltrate and the vasa recta bundles and peritubular capillaries involved in the countercurrent mechanism for urine osmoregulation. At E11.5 in mice, the UB is tracked by a primitive vessel that elaborates in synchrony with both UB branching and nephrogenesis. Capillaries form networks around the developing nephric tubules by E13.5, and the hilar artery and first-order interlobar renal artery branches can be identified by E14.5. These branches will form the corticomedullary arcades and interlobular arteries that branch from these arcades. Further branching produces the glomerular afferent arterioles. From E13.5 onward, endothelial cells migrate into the vascular cleft of developing glomeruli, where they undergo differentiation to form the glomerular capillary loops. The presence of endothelial cell–containing glomeruli becomes apparent at E14.5. The efferent arterioles carry blood away from the glomerulus to a system of fenestrated peritubular capillaries that are in close contact with the adjacent tubules and receive filtered water and solutes reabsorbed from the filtrate. These capillaries have few pericytes. In comparison, the vasa rectae, which surround the medullary tubules and are involved in urinary concentration, are also fenestrated but have more pericytes. They arise from the efferent arterioles of deep glomeruli. The peritubular capillary system surrounding the proximal tubules is well developed in the late fetal period, whereas the vasa rectae mature 1 to 3 weeks postnatally.
Model Systems to Study Kidney Development
The Kidney Organ Culture System
From the late 1950s, the method of growing mouse embryonic kidneys as floating cultures on top of filters, or more recently on transwell inserts ( Fig. 1.6 ), a technique pioneered by Clifford Grobstein and improved by Lauri Saxen, accelerated the advancement of the kidney developmental biology field. This classic method, which remains widely in use, has the advantages that the kidney explants are cultivated within an easily manipulated, controlled environment, and there is a possibility of visualizing the pattern of kidney growth by real-time fluorescence microscopy. Although vascularization and functional maturation are largely restricted in embryonic kidney explants, in vitro cultured kidneys display remarkable recapitulation of ureteric branching and epithelialization and segmental patterning of the MM. Historically, kidney explant cultures provided crucial proof for the principle of reciprocal tissue induction in organogenesis. They have been used to demonstrate that the UB and MM exchange inductive cues, driving branching morphogenesis of the UB and epithelialization of the MM. ,
Metanephric organ explants.
The top-left panels depict the schematic of kidney organ culture system with the floating membrane (upper panels) or transwell inserts (lower panels). Embryonic kidney explants are grown at the air–growth medium interface. E11.5 isolated embryonic kidney can be cultured as a whole (top right) or a combination of external Wnt sources and manually isolated MM (right middle and lower panels). Schematics of kidneys grown after 7 days of culture are shown on the right. The intact kidney explant retains the nephron progenitors in the periphery, while the progenitors within the isolated MM are exhausted when cultured with external Wnt signal sources.
As originally shown by Grobstein, Saxen, and colleagues, the two major components of the metanephric kidney, the MM and UB, could be separated from each other, and the isolated mesenchyme could be induced to form nephron-like tubules by other embryonic tissues, the best example of which is the embryonic neural tube, or more recently by Wnt-expressing feeder cells ( Fig. 1.6 ). When the neural tube is used to induce the separated mesenchyme, there is differentiation of the mesenchyme into tubules but not significant tissue expansion. In contrast, intact metanephric rudiments can grow more extensively, displaying both sustained UB branching and early induction of nephrons even when cultured for a week (see Fig. 1.6 ).
The isolated mesenchyme experiment has proven useful in the analysis of renal agenesis phenotypes, where there is no outgrowth of the UB. In these cases, the mesenchyme can be placed in contact with the neural tube to determine whether it has the intrinsic ability to differentiate. Most often, when renal agenesis is due to the mutation of a transcription factor acting in a cell-autonomous fashion in the MM (e.g., Wt1 ), tubular induction is not rescued by the neural tube (see Fig. 1.6 ). In the converse situation, in which renal agenesis is caused by loss of a gene function in the UB (e.g., Emx2 ), it is usually possible for the embryonic neural tube to induce tubule formation in isolated mesenchyme (see Fig. 1.6 ). Therefore the organ culture induction assay can be used to test hypotheses concerning whether a particular gene is autonomously required in the UB or MM.
Recently, various recombinant signaling ligands and chemical inhibitors specific for signal transduction pathways have become available. This has made it possible to add them to organ cultures and study the roles of specific signaling molecules and their downstream pathways in kidney development with greater time resolution, which is difficult to achieve in in vivo studies. Examples are the use of drugs to modulate the ERK/MAP kinase, PI3K/Akt, Notch signaling, and Fgf and Wnt signaling pathways in renal explant cultures. Most notably, the pleiotropic roles of Wnt signaling in nephron differentiation, , , NP self-renewal, and nephron patterning , have been extensively studied through in vitro experiments. These studies leverage the capabilities of in vitro culture experiments to dissect multiple parameters, such as concentration, duration, and downstream pathways of Wnt signaling.
Genetic Mouse Models
Many of the genetic pathways regulating kidney development are conserved between mice and humans. Due to the relative ease of manipulating the genome of the mouse, its small size, and shorter gestation period, the mouse has become the primary model organism for the study of mechanism of human development and diseases. Anatomic and functional features of the human kidney are highly similar in the mouse, albeit at a smaller scale, while a number of genes identified as essential for normal mouse kidney development are also known to be associated with congenital anomalies of the kidney and urinary tract (CAKUT) and other kidney diseases.
The wealth of our understanding of metanephric kidney development over the past few decades is owed to the harnessing of homologous gene recombination to introduce targeted mutations and novel alleles into specific genes in cultured mouse embryonic stem cells (ESCs). This paved the way for the creation of numerous genetically engineered mice that have become highly valuable tools for the study of renal developmental biology and the etiology of certain genetic diseases of the kidneys and urinary tract ( Table e1.1 ). The technology is applied in many ways. Its simplest way is creation of null mutations within the germline that generate gene knockout mouse models. The limitation of this method is that certain genes are essential for early development and their inactivation in the germline can cause premature lethality, thus precluding the analysis of the function of those genes in organogenesis. An improvement to this is the use of a conditional gene-targeting strategy, allowing for the creation of conditional alleles. This involves introducing small recognition sites for recombinase enzymes of which the Cre recombinase is the most routine now ( Fig. 1.7 ). A conditional “floxed” allele of the target gene locus is created by incorporating two loxP sites within two separate introns, flanking the exons that can be excised or recombined. In principle, normal transcription from the locus is expected before recombination of the floxed allele. The Cre recombinase is engineered under the control of a tissue-specific promoter. Breeding between tissue-specific transgenic Cre animals and those harboring a conditional allele for a particular gene ultimately results in a cell- or tissue-type specific inactivation of the gene of interest. This strategy has also been refined in some cases, so the Cre expression is temporally regulated using a drug such as doxycycline or tamoxifen. A number of Cre lines are now available to target genes specifically within different subpopulations of renal cells and progenitors. The transgenic Cre lines driven by the Hoxb7, Six2, Foxd1, and Nphs2 promoters are among the most highly cited gene excision drivers for targeted genetic inactivation in the ureteric, nephrogenic, stromal, and podocyte cell lineages. , Lately, the introduction of the more precise CRISPR-Cas9 gene editing tool, an ingenious application of the adaptive immune response of prokaryotes against bacteriophages, is facilitating the way researchers create customized mutant cells and animal models to study various aspects of renal development ( Fig. 1.8 ). The complex of guide RNAs and Cas9 proteins can be introduced directly into fertilized oocytes to rapidly generate mutant mice, so there is no need to manipulate mouse ESCs. This method is becoming increasingly popular, although great care must be taken to avoid off-target mutations.
Cre-lox homologous gene recombination system.
Simplified overview of Cre recombinase–mediated homologous recombination for generation of tissue-specific conditional null mutations of a target gene. Cre recombinase expression is engineered to be driven under the control of tissue-specific promoter (promoter TS ). The target gene (or typically certain exons within the target chromosomal locus) is flanked with loxP sites (recognition sites for Cre recombinase). Cre activity in specific cell types mediates the excision of the loxP-flanked (floxed) target gene, creating a null allele.
Gene editing using the CRISPR-Cas9 system.
Simplified overview for targeted introduction of mutations using the CRISPR-Cas9 system. Site-specific cleavage of a target gene locus with the Cas9 endonuclease creates a double-strand DNA break. The nicked target gene can be repaired by an error-prone, nonhomologous repair mechanism resulting in nucleotide insertion, deletion, or frameshift mutations. Introduction of a homologous engineered donor DNA results in a homologous substitution into the target locus, which then results in a precisely edited gene.
Table e1.1
Summary of Knockout and Transgenic Models for Kidney Development
| Gene Mutation or Knockout | Phenotype | Associated Human Diseases | References |
|---|---|---|---|
| Renal Agenesis | |||
| Celsr1 | Renal agenesis, hydroureter, hydronephrosis | Spina bifida, unilateral renal agenesis, hydronephrosis | |
| Ctnnb1 ( β -catenin) | Renal agenesis or severe renal hypoplasia, premature differentiation of UB epithelia (UB-selective) | Mental retardation, multiple cancers, eye defects | , |
| Emx2 | Renal agenesis | Schizencephaly (cerebral cleft abnormalities) | |
| Emx2, Pax2 | Duplicated kidneys and ureter, ureteral obstruction | CAKUT, VUR | |
| Esrp1 | Renal agenesis, renal hypoplasia | ||
| Etv4, Etv5 | Renal agenesis or severe renal hypodysplasia | , | |
| Eya1 | Renal agenesis | Branchiootorenal syndrome (brachial fistulae, deafness) | , |
| Fgf9, Fgf20 | Renal agenesis | ||
| Fgf10, Gdnf, Gfra1 | Renal agenesis | ||
| Fgfr1, Fgfr2 |
Renal agenesis
(MM-selective) |
||
| Fras1, Frem1, Frem2 | UB failure, defect of GDNF expression |
Fraser syndrome (cryptophthalmos, syndactyly, CAKUT);
Manitoba oculotrichoanal (MOTA) syndrome |
, , , , |
| Gata3 | Renal agenesis, gonad dysgenesis (null mutation) | Hypoparathyroidism, sensorineural deafness, and renal dysplasia (HDRS) syndrome; autoimmune disease | , , , |
| Gdf11 | UB failure, skeletal defects | , | |
| Gdnf, Gfra1, Ret | Renal agenesis or rudimentary kidneys, aganglionic megacolon |
Hirschsprung disease,
Multiple endocrine neoplasm type IIA/B (MEN2A/MEN2B), and familial medullary thyroid carcinoma (FMTC) |
, , , , , , , |
| Gen1 | Renal agenesis, duplex kidneys, hydronephrosis, ureteral obstruction | ||
| Gli3 | Renal agenesis, severe renal agenesis, absence of renal medulla and papilla | Pallister-Hall (PH) syndrome (polydactyly, imperforate anus, abnormal kidneys, defects in the gastrointestinal tract, larynx, and epiglottis) | , |
| Greb1l | Renal agenesis | CAKUT | , , |
| Grem1 | Renal agenesis; apoptosis of the MM | ||
| Grhl2 | Occasional unilateral renal agenesis, CD barrier dysfunction, diabetes insipidus | Autosomal dominant deafness, ectodermal dysplasia | , |
| Grip1 | Renal agenesis | Fraser syndrome (cryptophthalmos, syndactyly, CAKUT) | , , |
| Hnf1b | Renal agenesis, renal hypoplasia, hydroureter, duplex kidneys | CAKUT, diabetes mellitus, renal cysts, renal carcinoma | |
| Hoxa11, Hoxd11 | Distal limbs, vas deferens | Radioulnar synostosis with amegakaryocytic thrombocytopenia | |
| Hs2st1 | Lack of UB branching and mesenchymal condensation | ||
| Isl1 | Renal agenesis, renal hypoplasia, hydroureter (MM-selective) | ||
| Itga8 ( α 8 Integrin) | Renal agenesis, renal hypodysplasia | Fraser syndrome (cryptophthalmos, syndactyly, CAKUT) | |
| Itgb1 ( β 1 Integrin) | Renal agenesis, disrupted UB branching, hypoplastic collecting duct system (collecting duct–selective); podocyte dedifferentiation (podocyte-selective) | Fraser syndrome (cryptophthalmos, syndactyly, CAKUT) | , , |
| Kif26b | Renal agenesis, failed UB attraction to the MM | ||
| Lamc1 | UB failure, delayed nephrogenesis, water transport defects | ||
| Lhx1 (Lim1) | Renal agenesis (null mutant); renal hypoplasia, UB branching defect, hydronephrosis, distal ureter obstruction (UB-selective); arrested nephrogenesis, nephron-patterning defects (MM-selective) | Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome (müllerian duct agenesis) | , , |
| Lrp4 | Delayed UB induction, failed MM induction, syndactyly, oligodactyly | Cenani-Lenz syndrome | , , , |
| Mark2 (Par1b), Mark3 (Par1a) | Renal hypoplasia, proximal tubule dilation, immature glomeruli | ||
| Npnt | Delayed UB association with the MM | ||
| Osr1 | Lack of MM, adrenal gland, gonads, defects in formation of pericardium and atrial septum | , , , | |
| Pax2 | Renal hypoplasia, VUR | CAKUT, VUR, optic nerve colobomas | , |
| Pax2, Pax8 | Defect in intermediate mesoderm transition, failure of pronephric duct formation | CAKUT, VUR, optic nerve colobomas | |
| Pbx1 | Unilateral renal agenesis, expansion of nephrogenic precursors | CAKUT, hearing loss, abnormal ears | , , , |
| Ptf1a | Failure of UB induction, anal atresia, persistent cloaca, skeletal malformation | Pancreatic and cerebellar agenesis; diabetes mellitus | , , |
| Rara, Rarb | Renal hypoplasia, dysplasia, hydronephrosis, skeletal and multiple visceral abnormalities | , , | |
| Sall1 | Renal agenesis, severe renal hypodysplasia | Townes-Brock syndrome (anal, renal, limb, ear anomalies) | , |
| Shh | Bilateral or unilateral renal agenesis, unilateral ectopic dysplastic kidney, defective ureteral stromal differentiation | Vertebral defects, anal atresia, cardiac defects, tracheoesophageal fistula, renal anomalies, and limb abnormalities (VACTERL) syndrome | |
| Six1 | Lack of UB branching and mesenchymal condensation | Branchiootorenal syndrome | , |
| Sox8, Sox9 | Renal genesis, renal hypoplasia | Campomelic dysplasia (limb and skeletal defects, abnormal gonad development) | |
| Tln1, Tln2 | Renal agenesis | ||
| Wnt5a | Renal agenesis, renal dysplasia, duplex kidneys, hydronephrosis | CAKUT | , , |
| Wt1 | Renal and gonadal agenesis, severe lung, heart, spleen, adrenal, and mesothelial abnormalities | Wilms tumor, aniridia, genitourinary abnormalities, and retardation (WAGR) syndrome; Denys–Drash syndrome | , , , |
| Hypoplasia/Dysplasia/Low Nephron Mass | |||
| Adamts1 | Hypoplasia of the renal medulla, hydronephrosis | , | |
| Adamts1, Adamts4 | Hypoplasia of the renal medulla, hydronephrosis | ||
| Agtr2 | Various collecting duct defects | CAKUT | , , |
| Ald1a2 (Raldh2) | Renal hypoplasia, hydronephrosis, ectopic ureter | ||
| Bmp1ra (Alk3) | Hypoplasia of renal medulla, fewer UB branches (UB-selective) | Juvenile polyposis syndrome | |
| Bmp4 | Severe renal hypodysplasia | Microphthalmia, orofacial cleft | |
| Bmp7 | Renal hypoplasia, reduced MM survival | ||
| Cask | Renal hypoplasia and dysplasia, premature depletion of nephrogenic precursor cells | Microcephaly, mental retardation | , |
| Cdc42 | Renal hypoplasia, oligonephronia, defects in mesenchyme-to-epithelial transition (CM-selective) | , | |
| Cfl1 | Renal hypodysplasia, ureter duplication | ||
| Chd4 (Mi-2 β ) | Renal hypodysplasia | Sifrim-Hitz-Weiss syndrome (autosomal dominant intellectual disability disorder with variable congenital defects in cardiac, skeletal, and urogenital systems) | , |
| Ctnnb1 ( β -catenin) | Severely hypoplastic kidney, lack of nephrogenic zone and S-shaped body (CM-selective) | Mental retardation, multiple cancers, eye defects | |
| Dchs1, Dchs2 | Renal hypoplasia, impaired ureteric branching, expansion of nephrogenic precursor zone | Van Maldergem syndrome 1—periventricular nodular heterotopia, intellectual disability, deafness, renal hypoplasia, tracheal anomalies, and skeletal dysplasia | , , |
| Dicer1 | Renal hypoplasia, dysplasia, cysts (UB-selective); renal hypoplasia characterized by premature termination of nephrogenesis (MM-selective) | , | |
| Dkk1 | Overgrown renal papilla (renal tubule and collecting duct restricted) | ||
| Dlg1 | Renal hypoplasia and dysplasia, premature depletion of nephrogenic precursor cells | , | |
| Dstn (Destrin) | Renal hypodysplasia, ureter duplication | ||
| Egfr | Hypoplasia of the renal papilla, moderate polyuria, and urine concentration defects | ||
| Egln1 (Phd2), Egln3 (Phd3) | Renal hypoplasia, oligonephronia, abnormal postnatal nephron formation, glomerulosclerosis (stroma-specific) | Familial erythrocytosis; abnormally high EPO levels; high altitude adaptation hemoglobin (HALAH) | |
| Esrrg | Agenesis of renal papilla | ||
| Fat4 | Renal hypoplasia, impaired ureteric branching, failed nephrogenesis (mesenchyme-to-epithelial transition), expansion of nephrogenic precursor zone (stroma-selective) | Van Maldergem syndrome 2 (VMLDS2): dysmorphic faces, tracheomalacia, microtia, intellectual disability, and skeletal dysplasia | , , , |
| Fgf7 | Small kidneys, reduction in nephron number | ||
| Fgf8 | Renal dysplasia, arrested nephrogenesis at pretubular aggregate stage (MM-selective) | Kallmann syndrome, hypogonadism | , |
| Fgf10 | Renal hypoplasia, multiorgan developmental defects, including the lungs, limb, thyroid, pituitary, and salivary glands | ||
| Fgfr1, Fgfr2 | Renal agenesis (MM-selective) | ||
| Fgfr2 | Renal hypoplasia, hydronephrosis (UB-selective) | ||
| Foxc2 | Renal hypoplasia | Lymphedema-distichiasis syndrome | , |
| Foxd1 | Accumulation of undifferentiated CM, attenuated UB branching, stromal patterning defects | , , | |
| Frs2 | Mild renal hypoplasia (UB-selective) | ||
| Fzd4, Fzd8 | Impaired UB branching, renal hypoplasia | ||
| Hdac1, Hdac2 | Renal hypoplasia, renal dysplasia, arrest of nephrogenesis at the renal vesicle stage | , | |
| Lats1, Lats2 | Renal hypoplasia, impaired UB branching and UB tip specification, impaired nephrogenesis, and renal interstitial differentiation | , | |
| Lgr4 | Severe renal hypoplasia and oligonephronia; renal cysts | Aniridia-genitourinary anomalies; mental retardation | , |
| Lmx1b | Renal dysplasia, skeletal abnormalities | Nail–patella syndrome | , |
| Map2k1 (Mek2), Map2k (Mek1) | Renal hypodysplasia, megaureter | Cardiofaciocutaneous syndrome | |
| Mdm2 | Renal hypoplasia and dysplasia, severely impaired UB branching and nephrogenesis (UB-selective); depletion of nephrogenic precursors (MM-selective) | , | |
| Mf2 | Renal hypoplasia, oligonephronia | ||
| Mitf | Oligonephronia | Microphthalmia, Waardenburg syndrome type 2A | |
| Nf2 | Renal hypoplasia, renal dysplasia | ||
| Notch1, Notch2 | Loss of nephron derivatives, nephron segmentation defects | Alagille syndrome (cholestatic liver disease, cardiac disease, kidney dysplasia, renal cysts, renal tubular acidosis) | |
| Pbx1 | Reduced UB branching, expansion of nephrogenic precursors, delayed mesenchyme-to-epithelial transformation, dysgenesis of adrenal gland and gonads | , | |
| Plxnb2 | Renal hypoplasia and ureter duplication | ||
| Pou3f3 (Brn1) | Impaired development of distal tubules, loop of Henle, and macula densa; distal nephron–patterning defect | ||
| Prr | Renal hypoplasia, renal dysplasia, oligonephronia | , | |
| Psen1, Psen2 | Severe renal hypoplasia, severe defects in nephrogenesis | ||
| Ptgs2 | Oligonephronia | ||
| Rbpj | Severe renal hypoplasia, oligonephronia, loss of proximal nephron segments, tubular cysts (MM-selective) | , | |
| Sall1 | Severe renal hypoplasia, cystic dysplasia of nephrogenic derivatives (tubules and glomeruli) | Townes-Brocks branchiootorenal–like syndrome | |
| Shp2 | Severe impairment of UB branching, renal hypoplasia | ||
| Six1 | Hydronephrosis, hydroureter, abnormal development of ureteral smooth muscle | ||
| Six2 | Renal hypoplasia and premature depletion of nephrogenic precursors (homozygous loss); increased UB branching and augmentation of nephron endowment (haploinsufficiency) | , | |
| Tbx18 | Hydronephrosis, hydroureter, abnormal development of ureteral smooth muscle | , | |
| Tfap2b | MM failure, craniofacial and skeletal defects | ||
| Trp53 (p53) | Oligonephronia, precocious depletion of nephrogenic precursors | Multiple cancers | |
| Trps1 | Impaired UB branching, renal hypoplasia | Trichorhinophalangeal syndrome (skeletal defects) | |
| Vangl2 | Impaired UB branching and renal hypoplasia | Neural tube defects | |
| Wnt4 | Failure of MM induction | ||
| Wnt7b | Complete absence of medulla and renal papilla (UB-selective) | ||
| Wnt9b | Vestigial kidney, failure of MM induction; cystic kidney (CD-selective) | , | |
| Wnt11 | Impaired ureteric branching, renal hypoplasia | ||
| Yap | Renal hypoplasia renal dysplasia, hydronephrosis, severe disruption of UB branching (UB-selective), oligonephronia, defects in mesenchyme-to-epithelial transition (CM-selective) | Coloboma, hearing impairment, cleft palate, cognitive deficit, hematuria | , , |
| Mislocalized or Ectopic UB/Increased UB Branching | |||
| Bmp4 | Duplex ureter, hydroureter, renal hypodysplasia | Microphthalmia, orofacial cleft | |
| Cer1 | Increased ureteric branching, altered spatial organization of ureteric branches | ||
| Cfl1 | Renal hypodysplasia, ureter duplication | ||
| Foxc1 | Duplex kidneys, ectopic ureters, hydronephrosis, hydroureter | ||
| Gata3 | Ectopic ureteric budding, duplex kidneys, hydroureter (UB-selective) | Hypoparathyroidism, sensorineural deafness, and renal dysplasia (HDRS) syndrome; autoimmune disease (rheumatoid arthritis) | , , , |
| Hnf1b, Pax2 | Renal hypoplasia, duplex kidneys, ectopic ureters, megaureter, hydronephrosis | CAKUT | |
| Hspb11 (Ift25) | Duplex kidneys | ||
| Ift27 | Duplex kidneys | ||
| Lzts2 | Duplex kidneys/ureters, hydronephrosis, hydroureter | ||
| Plxnb1 | Increased ureteric branching | ||
| Plxnb2 | Renal hypoplasia and ureter duplication | ||
| Robo2 | Increased UB branching | CAKUT, VUR | , |
| Ror2 | Duplex ureter, hydronephrosis | Skeletal dysplasia, shortened limbs, brachydactyly, facial dysmorphia (brachydactyly, type B1, Robinow syndrome) | , |
| Sema3a | Increased ureteric branching (UB-selective) | ||
| Slit2 | Increased UB branching | CAKUT, VUR | , |
| Spry1 | Supernumerary UBs, multiple ureters | , | |
| Wnt5a | Duplex ureter, hydronephrosis | Robinow syndrome (skeletal dysplasia, shortened limbs, brachydactyly, facial dysmorphia) | , |
| Renal Cysts | |||
| Angpt1, Angpt2 | Interstitial medullary cysts, urinary concentration defects | ||
| Aqp11 | Abnormal vacuolization of proximal tubules; polycystic kidneys | ||
| Arhgap35 (GRLF1) | Glomerular cysts | ||
| Bcl2 | Renal hypoplasia and cysts | ||
| Bicc1 | Polycystic kidneys | ||
| Bpck | Polycystic kidneys, hydrocephalus | Meckel syndrome 3 | |
| Erbb4 |
Renal cysts (overexpression in renal tubules)
Dilated and mispolarized tubules, increased renal fibrosis (renal tubule deletion) |
||
| Fat4 | Renal cysts, disrupted hair cell organization in inner ear | Van Maldergem syndrome (mental retardation, abnormal craniofacial features, deafness, limb malformations, renal hypoplasia | , |
| Glis3 | Polycystic kidney, neonatal diabetes | Congenital hypothyroidism, diabetes mellitus, hepatic fibrosis, congenital glaucoma | , |
| Gpc3 | Disorganized tubules and medullary cysts | Simpson-Golabi-Behmel syndrome | , , |
| Hnf1b | Polycystic kidney disease (tubule-selective) | CAKUT, diabetes mellitus, renal cysts, renal carcinoma | , , |
| Ift88 (Orpk) | Polycystic kidneys; defective left-right asymmetric patterning | ARPKD | , |
| Ilk | Medullary cysts (stroma-specific) | ||
| Invs | Polycystic kidneys, inverted viscera | Nephronophthisis | , |
| Kif3A | Polycystic kidney disease (tubule-selective) | ||
| Mafb (Kreisler) | Decreased glomeruli, cysts, and tubular dysgenesis | Musculoaponeurotic fibrosarcoma | , |
| Mks1 | Renal hypoplasia and cysts | Meckel syndrome (multicystic dysplasia, neural tube defect) | |
| Pkd1, Pkd2 | Renal cysts | ADPKD, ARPKD | |
| Pten | Abnormal ureteric bud branching, cysts (UB-selective) | Cowden disease, Bannayan-Riley-Ruvalcaba syndrome, various tumors | |
| Sall1 | Nephrogenic tubule and glomerular cysts (stroma specific) | Townes-Brocks branchiootorenal–like syndrome | |
| Taz | Polycystic kidneys, emphysema | , | |
| Tek (Tie2) | Interstitial medullary cysts, urinary concentration defects | Cutaneous and mucosal venous malformation, congenital glaucoma | |
| Vhl | Renal cysts (tubule-selective) | Von Hippel-Lindau syndrome | |
| Xylt2 | Polycystic kidneys and liver | ||
| Zeb2 | Glomerular cysts | Mowat-Wilson syndrome (Hirschsprung disease with associated mental retardation) | |
| Later Phenotypes (Tubular, Vascular, and Glomerular Defects) | |||
| Ace | Atrophy of renal papillae, vascular thickening and hypertrophy, perivascular inflammation | Chronic systemic hypotension | , |
| Actn4 | Glomerular developmental defects, FSGS | SRNS | , |
| Adam10 | Loss of principal cells of the CD, hydronephrosis, polyuria | Alzheimer disease; reticulate acropigmentation of Kitamura | |
| Agt | Atrophy of renal papillae, vascular thickening and hypertrophy, perivascular inflammation | Chronic systemic hypotension | , |
| Agtr1a (AT1A) | Hypertrophy of juxtaglomerular apparatus and expansion of renin cell progenitors, mesangial cell hypertrophy | Chronic systemic hypotension | |
| Agtr1a/Agtr1b (AT1A/AT1B) | Atrophy of renal papillae, vascular thickening and hypertrophy, perivascular inflammation | Chronic systemic hypotension | |
| Ampd | Podocyte foot process effacement, proteinuria | Minimal change nephropathy | |
| Angpt1 | Simplification and dilation of glomerular capillaries; detachment of glomerular endothelium from the GBM; loss of mesangial cells; loss of ascending vasa recta (compound deletion with Angpt2) | , | |
| Angpt2 | Cortical peritubular capillary abnormalities (null allele); apoptosis of glomerular capillaries, proteinuria (transgenic overexpression); loss of ascending vasa recta (compound deletion with Angpt1) | , , | |
| Arhgdia (RhoGDI α ) | Podocyte effacement and proteinuria | SRNS, FSGS | , , |
| Bmp7 | Hypoplastic kidney, impaired maturation of nephron, reduced proximal tubules (podocyte-selective) | ||
| Cd151 | Podocyte foot process effacement, disorganized GBM, tubular cystic dilation | Nephropathy (FSGS) associated with pretibial epidermolysis bullosa and deafness | , |
| Cd2ap | Podocyte effacement, proteinuria | FSGS | |
| Cdc42 | Congenital nephrosis; impaired formation of podocyte foot processes (podocyte-selective) | ||
| Cmas | Congenital nephrosis; impaired formation of podocyte foot processes, defective sialylation | ||
| Col4a1, Col4a3, Col4a4, Col4a5 | Disorganized GBM, proteinuria | Alport syndrome | , , , |
| Coq6 | Nephrotic syndrome and deafness | SRNS, FSGS, sensorineural deafness | , |
| Crb2 | Podocyte effacement and proteinuria | SRNS, FSGS | |
| Crk1, Crk2, CrkL | Albuminuria, altered podocyte cytoarchitecture (podocyte-selective) | ||
| Cxcl12 (SDF1), Cxcr4, Cxcr7 | Petechial hemorrhage in the kidneys, glomerular aneurysm, fewer glomerular fenestrations, reduced mesangial cells, podocyte foot process effacement, mild renal hypoplasia | WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome | , , |
| Dicer1 | Podocyte damage, albuminuria, end-stage renal failure (podocyte-selective); reduced renin production, renal vascular abnormalities, striped fibrosis (renin cell–selective) | Pleuropulmonary blastoma | , , , |
| Dnm1, Dnm2 (Dynamin 1/2) | Podocyte foot process effacement and proteinuria (podocyte-selective) | ||
| Dot1l | Increased intercalated at the expense of principal CD cells; polyuria | , | |
| Efnb1 (Ephrin B1) | Podocyte foot process effacement and proteinuria (podocyte-selective) | ||
| Efnb2 (Ephrin B2) | Dilation of glomerular capillaries | ||
| Egln1 (Phd2), Egln3 (Phd3) | Renal hypoplasia, oligonephronia, abnormal postnatal nephron formation, abnormally elevated erythropoietin production, dilation of renal blood vessels, glomerulosclerosis (stroma-specific) | Familial erythrocytosis; abnormally high EPO levels; high altitude adaptation hemoglobin (HALAH) | |
| Elf5 | Paucity in principal CD cells | ||
| Fat1 | Foot process fusion, failure of foot process formation, proteinuria | SRNS, FSGS, hematuria with neurologic defects; glioblastoma, colorectal cancer, head and neck cancer | , |
| Fermt2 (Kindlin-2) | Rac1 hyperactivation, podocyte effacement and proteinuria | ||
| Flt1 (Vegfr1) | Nephrotic syndrome | ||
| Foxc1 and Foxc2 | Impaired podocyte differentiation, dilated glomerular capillary loop, poor mesangial migration; proteinuria and glomerulosclerosis | Anterior segment dysgenesis/Axenfeld-Rieger syndrome (iris hypoplasia and defective cornea); lymphedema-distichiasis syndrome (lower limb swelling and extra eyelashes) | , , |
| Foxi1 | Tubular acidosis; absence of CD intercalated cells | Tubular acidosis and deafness | , |
| Fyn | Podocyte foot process effacement, abnormal slit diaphragms, proteinuria | , | |
| Gata3 | Impaired maintenance of mesangial cells, dilation of glomerular capillaries, glomerulosclerosis and mesangial matrix expansion, proteinuria | ||
| Gnas (Gαs) | FSGS, mesangial expansion, proteinuria, urinary concentration defect (renin cell–specific) | Pseudohypoparathyroidism, McCune-Albright syndrome, endocrine tumors | , |
| Gne (Mnk) | Hyposialylation defect, foot process effacement, GBM splitting, proteinuria, and hematuria | ||
| Grhl2 | Occasional unilateral renal agenesis, CD barrier dysfunction, diabetes insipidus | Autosomal dominant deafness, ectodermal dysplasia | , |
| Ilk | Nephrotic syndrome (podocyte-selective); collecting duct obstruction (UB-selective) | , | |
| Insr | Podocyte effacement, GBM alteration, proteinuria (podocyte-selective) | Diabetic nephropathy | |
| Itga3 (Integrin α3) | Reduced UB branching, glomerular defects, poor foot process formation | , | |
| Itga6 (Integrin α6) | Collecting duct dilation and dysplasia | Epidermolysis bullosa, collecting duct dysplasia | |
| Itgb1 (Integrin β1) | Podocyte loss, capillary and mesangial degeneration, glomerulosclerosis (podocyte-selective) | , | |
| Itgb4 (Integrin β4) | CD dilation and dysplasia | Epidermolysis bullosa | |
| Kdr (Flk1/Vegfr2) | Thrombotic microangiopathy, ascites; renal papilla dysplasia, urine concentration defects, loss of peritubular papillary capillaries (stroma specific) | Capillary infantile hemangioma | , |
| Kirrel (Neph1) | Abnormal slit diaphragm function, FSGS | ||
| Lama5 | Defective glomerulogenesis, abnormal GBM, poor podocyte adhesion, loss of mesangial cells | ||
| Lamb2 | Proteinuria prior to the onset of foot process effacement | Pierson syndrome | , |
| Lmx1b | Impaired differentiation of podocytes, cytoskeletal disruption in podocytes | Nail–patella syndrome | , , |
| Mafb (Kreisler) | Abnormal podocyte differentiation | ||
| Magi2 | Podocyte effacement and proteinuria | SRNS, FSGS | , , |
| Mib1 | Loss of principal CD cells, polyuria, urine concentration defects, sodium wasting, hydronephrosis | Left ventricular noncompaction | |
| Mpp5 (Pals1) | Tubular cysts, podocyte effacement, and proteinuria | ||
| Mpv17 | Nephrotic syndrome | ||
| Mtor | Proteinuria, podocyte autophagy defects (podocyte-selective) | ||
| Myo1E | Podocyte foot process effacement and proteinuria | SRNS | , , |
| Nck1, Nck2 | Failure of foot process formation (podocyte-selective) | ||
| Nid1 | Abnormal GBM | ||
| Notch1, Notch2 | Lack of glomerular endothelial and mesangial cells (standard knockout) lack of podocytes and proximal tubular cells (MM-selective); impaired nephrogenesis (cap mesenchyme–selective) | Alagille syndrome (cholestatic liver disease, cardiac disease, kidney dysplasia, renal cysts, renal tubular acidosis) | , , , |
| Nphs1 (Nephrin) | Absent slit diaphragms, podocyte effacement, proteinuria | Congenital nephrosis of the Finnish type, childhood-onset steroid-resistant nephritic syndrome, childhood- and adult-onset FSGS | |
| Nphs2 (Podocin) | Congenital nephrosis, FSGS, vascular defects | SRNS, FSGS | , |
| Npnt | Mislocalization of α8β1 integrin, mesangial hyperproliferation and sclerosis (nephron and podocyte-specific deletion) | ||
| Nrp1 | Glomerular aneurysm, impaired mesangial development, glomerulosclerosis | ||
| Par1a, Par1b | Proximal tubule dilation and immature glomeruli | ||
| Pdgfb, Pdgfrb | Lack of mesangial cells, ballooned glomerular capillary loop | , | |
| Pik3c3 (Vps34) | FSGS, defects in vesicular trafficking (podocyte-selective) | , | |
| Podxl | Podocyte effacement, reduced glomerular capillary fenestrae, abnormal GBM, anuria | Congenital FSGS, omphalocele, and microcoria | , |
| Prkci (aPKCλ/ι) | Defect of podocyte foot processes, nephrotic syndrome (podocyte-selective) | , | |
| Ptpro (GLEPP1) | Broadened podocyte foot processes with altered interdigitation patterns | SRNS | , |
| Rab3A | Albuminuria, disorganization of podocyte foot process structure | ||
| Rbpj |
Decreased renal arterioles, absence of mesangial cells, and depletion of renin cells (stromal cell–selective)
Reduction in juxtaglomerular cells, impaired renin synthesis (renin cell–selective) Loss of principal CD cells (UB-specific) |
, , | |
| Rhpn1 | FSGS, podocyte foot process effacement, GBM thickening | ||
| Robo2 | Abnormal pattern of podocyte foot process interdigitation, focal effacement of foot processes, proteinuria | CAKUT, VUR | |
| Scl5a2 (SGLT2) | Elevated urinary excretion of glucose, calcium, and magnesium | Glucosuria | |
| Sh3gl1, Sh3gl2, Sh3gl3 (Endophilin 1/2/3) | Podocyte foot process effacement and proteinuria, neuronal defects | ||
| Sirpa | Irregular podocyte foot process interdigitation, mild proteinuria | ||
| Sox4 | Oligonephronia, podocyte effacement, GBM defects (MM-selective) | ||
| Sox17, Sox18 | Vascular insufficiency in kidneys and liver; ischemic atrophy of renal and hepatic parenchyma; defective postnatal a | HLT (hypotrichosis-lymphedema-telangiectasia) syndrome (hair, vascular, and lymphatic disorder) | , |
| Sv2b | Podocyte foot process effacement and proteinuria | ||
| Synj1 | Podocyte foot process effacement and proteinuria; neuronal defects | ||
| Tcf21 (Pod1) | Lung and cardiac defects, sex reversal and gonadal dysgenesis, vascular defects, disruption in UB branching, impaired podocyte differentiation, dilated glomerular capillary, poor mesangial migration | , , | |
| Tek (Tie2) | Loss of ascending vasa recta and medullary capillary plexus, urinary concentration defects | Cutaneous and mucosal venous malformations, congenital glaucoma | |
| Tfcp2l1 | Loss of CD intercalated cells | ||
| Tjp1 (ZO-1) | Podocyte effacement and proteinuria | ||
| Trp63 (TP63) | Loss of CD intercalated cells | ADULT (acro-dermato-ungual-lacrimal-tooth) syndrome; limb-mammary syndrome | |
| Trpc6 | Protected from angiotensin-mediated or proteinuria or complement-dependent glomerular injury (null mutation); podocyte foot process effacement and proteinuria (transgenic overexpression in the podocyte lineage) | SRNS, FSGS | , , , , , , |
| Vangl2 | Immature and poorly branched glomerular tuft | Neural tube defects | |
| Vegfa | Endotheliosis, disruption of glomerular filtration barrier formation, nephrotic syndrome (podocyte-selective); peritubular capillary rarefaction and polycythemia (tubule-specific) | , , , | |
| Vhl | Glomerulonephritis (podocyte-selective) | Von Hippel-Lindau syndrome | |
| Wasl (N-wasp) | Podocyte effacement, proteinuria | ||
| Wnt7b | Impaired development medullary microvasculature | ||
| Wnt11 | Glomerular cysts | ||
ADPKD, Autosomal dominant polycystic kidney disease; ARPKD, autosomal recessive polycystic kidney disease; CAKUT, congenital anomalies of the kidney and urinary tract; CD, collecting duct; CM, cap mesenchyme; FSGS, focal segmental glomerulosclerosis; GBM, glomerular basement membrane; GDNF, glial cell–derived neurotrophic factor; MM, metanephric mesenchyme; SRNS, steroid-resistant nephrotic syndrome; UB, ureteric bud; VUR, vesicoureteral reflux.
Significant innovations in high-throughput gene sequencing are also facilitating the identification of monogenic mutations associated with heritable kidney diseases. , Putative disease-causing genes identified from genome-wide association studies can then be validated in corresponding gene-targeted mouse models. Similarly, a gene whose mutation has been identified to cause kidney maldevelopment and dysfunction in mice can be investigated for incidence of mutations across the human genome (e.g., Arhgdia in nephrotic syndrome). Other genome-wide approaches that have led to the discovery of novel genes in kidney development and disease include gene trap consortia , and genome-wide transcriptome and proteome projects.
Imaging and Lineage Tracing Studies
Reporter mouse lines are animal models engineered to express transgenes encoding a fluorescent protein tag or an enzyme (e.g., bacterial β-galactosidase) in a cell lineage–specific manner. In the simplest model, a single transgene comprising the reporter coding region is placed downstream of a cell-specific promoter. Such a model is useful to identify and follow distinct cell lineages where the chosen promoter is active. Hoxb7-EGFP was the first fluorescent transgene developed to visualize renal development. Enhanced green fluorescent protein (EGFP), placed under the control of the Hoxb7 promoter, specifically labels the Wolffian duct and the ureteric epithelial lineage. Hoxb7-EGFP has therefore proven to be invaluable in studying the rates and pattern of ureteric branching morphogenesis and ureteral development, including disruption of these events in the context of particular mutant backgrounds. , An alternative model uses two separate transgenes, namely a cell-specific Cre driver and an independent reporter transgene (e.g., R26R). With the R26R reporter model, expression of fluorescent protein gene (e.g., tdTomato) or β-galactosidase transgene is switched on by a Cre-mediated removal of an upstream stop codon. Inducible reporter systems incorporate genetic regulatory elements that allow for both cell-specific promoter- and drug-dependent activation of the reporter gene. The most commonly used strategies for controlled transgene expression in mice are the Tet-operon/repressor bi-transgenic and the estrogen receptor ligand-binding domain (Cre-ERT2) systems. These inducible reporter systems allow for timed pulse labeling of cell lineages, resulting in permanent tagging of progenitor cells and their direct derivatives. Inducible reporter systems have become valuable tools for the mapping of cell fates. Inducible reporter systems have been used to establish that the Six2 + cells are the progenitors of all epithelial structures of the mature nephron (see Fig. 1.5 ). In some cases, the Cre transgene is engineered with an associated fluorophore expression cassette (e.g., GFP-Cre fusion gene) under the control of a shared promoter, thus allowing easy identification of cells with targeted gene mutations. A wide variety of reporter and Cre transgenes (see Table e1.1 ) are now available to characterize the development and organization of multiple compartments of the kidney.
Reporter mice expressing fluorescent tags also come in handy for segregating and isolating particular cell types on the basis of fluorescence, facilitating global gene expression analysis, elucidation of transcriptional regulatory networks, and epigenetic interactions that orchestrate particular morphogenetic events ( Table 1.2 ). Purified populations of fluorescence-tagged cells can be used for high-throughput discovery of transcriptomes, genome-wide DNA-binding protein interactions, histone modifications, and nucleosome complexes through next-generation sequencing methods such as RNA-seq (RNA sequencing) and ChIP-seq (chromatin immunoprecipitation sequencing).
Table 1.2
Mouse Strains for Conditional Gene Targeting and Lineage Marking of Cells
| Gene Promoter | Cre | rtTA | Cre-ERT2 | Fluorescent Reporter | Renal Expression | Extrarenal Expression | Reference |
|---|---|---|---|---|---|---|---|
| 11Hsd2 | ✓ | ✓ | Principal cells of collecting duct, connecting tubules | Amygdala, cerebellum, colon, ovary, uterus, epididymis salivary glands | |||
| Aqp2 | ✓ | ✓ | Principal cells of collecting duct | Testis, vas deferens | |||
| Atp6v1b1 | ✓ | ✓ | Collecting ducts (intercalated cells), connecting tubule | , | |||
| Bmp7 | ✓ | ✓ | ✓ | Cap mesenchyme | |||
| Cdh16 (Ksp-Cadherin) | ✓ | ✓ | Renal tubules, collecting ducts, ureteric bud, Wolffian duct, mesonephros | Müllerian duct | , | ||
| Cited1 | ✓ | ✓ | Cap mesenchyme | ||||
| Emx1 | ✓ | ✓ | ✓ | Renal tubules (proximal and distal tubules) | Cerebral cortex, thymus | ||
| Foxd1 | ✓ | ✓ | ✓ | Stromal cells | |||
| Gdnf | ✓ | ✓ | Cap mesenchyme | ||||
| Ggt1 | ✓ | Cortical tubules | |||||
| Hoxb6 | ✓ | ✓ | Metanephric mesenchyme | Lateral mesoderm, limb buds | , | ||
| Hoxb7 | ✓ | ✓ | ✓ | Ureteric bud, wolffian duct, collecting ducts, distal ureter | Spinal cord, dorsal root ganglia | ||
| Kap | ✓ | Proximal tubules | Brain | , | |||
| Klf3 | ✓ | Collecting ducts | Gonads | GUDMAP a | |||
| Nphs1 | ✓ | ✓ | ✓ | Podocytes | Brain | , | |
| Nphs2 | ✓ | ✓ | ✓ | Podocytes | |||
| Osr1 | ✓ | ✓ | ✓ | Metanephric mesenchyme | Intermediate mesoderm | , | |
| Osr2 | ✓ | Condensing metanephric mesenchyme; glomeruli | Palatal mesenchyme | ||||
| Pax2 | ✓ | ✓ | Pronephric duct, wolffian duct, ureteric bud, cap mesenchyme | Inner ear, midbrain, cerebellum, olfactory bulb | |||
| Pax3 | ✓ | Metanephric mesenchyme | Neural tube, neural crest | , , | |||
| Pax8 | ✓ | ✓ | ✓ | ✓ | Renal tubules (proximal and distal tubules) and collecting ducts (Tet-On inducible system) | , | |
| Pck1 | ✓ | ✓ | ✓ | Proximal tubules | Liver | ||
| Pdgfb | ✓ | Endothelium | Systemic vascular endothelium | ||||
| Pdgfrb | ✓ | ✓ | ✓ | ✓ | Mesangial cells, vascular smooth muscles | Pericytes, vascular smooth muscles | , , |
| Prox1 | ✓ | ✓ | ✓ | Ascending vasa recta, lymphatic vessels | Systemic lymphatic vasculature | , , | |
| Rarb | ✓ | ✓ | Metanephric mesenchyme | ||||
| Ren1 | ✓ | ✓ | ✓ | Juxtaglomerular cells, afferent arterioles, mesangial cells | Adrenal gland, testis, sympathetic ganglia | ||
| Ret | ✓ | Ureteric bud, collecting ducts | Dorsal root ganglion, neural crest | ||||
| Sall1 | ✓ | ✓ | Metanephric mesenchyme (tamoxifen-inducible system) | Limb buds, central nervous system, heart | |||
| Six2 | ✓ | ✓ | ✓ | ✓ | Cap mesenchyme | ||
| Slc22a6 | ✓ | Proximal tubules | |||||
| Slc5a2 | ✓ | Proximal tubules | |||||
| Sox18 | ✓ | Cortical and medullary vasculature | Blood vessels and precursor of lymphatic endothelial cells | , , | |||
| Spink3 | ✓ | Medullary tubules (distal or connecting tubules?) | Mesonephric tubules, pancreas, lung, liver, gastrointestinal tract | , , | |||
| T (Brachyury) | ✓ | ✓ | Whole kidney (both ureteric bud and metanephric mesenchyme) | Pan-mesodermal | |||
| Tbx18 | ✓ | Ureteral mesenchyme | Heart, limb buds | ||||
| Tcf21 | ✓ | Metanephric mesenchyme, cap mesenchyme, podocytes, stromal cells | Epicardium, lung mesenchyme, gonad, spleen, adrenal gland | ||||
| Tek | ✓ | ✓ | ✓ | ✓ | Endothelium | Systemic vasculature endothelium | , , |
| Tie1 | ✓ | ✓ | Endothelium | Systemic vasculature endothelium | |||
| Umod | ✓ | ✓ | Thick ascending limbs of loops of Henle | Testis, brain | |||
| Wnt4 | ✓ | ✓ | ✓ | Renal vesicles, nascent nephrons (comma- and S-shaped bodies) | Lungs, developing gonads | , |
Cre (noninducible Cre recombinase transgene); rtTA (reverse tetracycline transactivator, tetracycline-inducible expression system); Cre-ERT2 (Cre-estrogen receptor ligand binding domain fusion transgene, tamoxifen-inducible expression system); fluorescent reporter (promoter-driven expression of a fluorescent protein, such as green fluorescent protein and its variants.)
Kidney Organoids
Recent advances in synthetic biology using an “understanding by creating” approach have enabled the ex vivo generation of kidney tissues from pluripotent stem cells (PSCs), namely kidney organoids ( Fig. 1.9 ). These PSC-derived kidney organoids can form many renal structures including the glomerulus, proximal tubule, loop of Henle, distal tubule, collecting ducts, interstitium, and a primitive endothelial network. This breakthrough, in turn, has served as a tool to validate the efficacy of lineage-specifying signaling molecules identified through in vivo studies. The feasibility of screening using in vitro experimental setups has significantly enhanced our understanding of kidney lineage specification with unprecedented resolution, particularly in analyzing signal concentration, combinations, timing, and duration aspects that are not readily apparent in in vivo analyses. In addition, organoids with gene-edited PSCs using CRISPR-Cas9 technology (see Fig. 1.8 ) provide a unique opportunity for a time- and cost-effective strategy to interrogate novel gene functions relevant to embryonic kidney development in not only mice but also humans. In addition, the selective induction protocol of either NP or UB lineage allowed the cell-autonomous role of commonly expressed genes, such as PAX2, in nephron and the collecting duct development to be addressed. , Such gene-edited organoids or patient PSC-derived organoids are being used to model various genetic diseases including podocyte diseases, ciliopathies, and polycystic diseases. These efforts will eventually lead to discovery of curative drugs. Another long-term goal of kidney organoid research is kidney replacement therapy. However, the currently available kidney organoids are immature and lack ureters and a proper vascular network. , A deeper understanding of the developmental processes in vivo will be required to generate transplantable kidneys ex vivo.
Generation of kidney organoid based on development.
Representative-directed differentiation protocols of pluripotent stem cells (PSCs) toward nephron progenitor (NP), ureteric bud (UB), and stromal progenitor (SP) lineages are summarized. Induced progenitors are further differentiated to form nephron organoids (right upper panel) or ureteric bud organoids (right middle panel), or they are reassembled to reconstitute higher-order kidney structures (right lower panel). Commonly used signaling molecules among multiple reports are shown in bold. A factor specifically used in human PSC differentiation is shown in red. AIM, Anterior intermediate mesoderm; ECM, extracellular matrix; PIM, posterior intermediate mesoderm; PS, primitive streak; PSC, pluripotent stem cell; RA, retinoic acid; TBM, tail bud mesenchyme; WD, Wolffian duct.
Single-Cell Analysis of the Embryonic Kidney and Synthetic Kidney
The kidney, including the embryonic kidney, contains numerous cell types, with each cell type consisting of a limited number of cells. Conventional transcriptomic techniques, which usually require thousands of cells, result in the averaged property of the whole kidney or sorted limited fractions of cell types. The newly emerging scRNA-seq technology has revolutionized the field of kidney development research. It can measure transcriptomic information of a few tens of thousands of cells, with a depth of a few thousand genes per single cell, facilitating the collection of transcriptomic data from entire tissues or embryos. Moreover, advances in bioinformatics tools have enabled computational retrospective recovery of cell types, eliminating the need to presort the target cell of interest and even allowing identification of previously unknown subpopulations. , Indeed, this technique has allowed the identification of multiple cell types in the embryonic and adult kidney and many representative genes expressed in each cell type including not only nephrons and collecting ducts but also interstitial cells, mesangial cells, and the vasculature. , The scope of the analysis has been extended from mouse to human embryonic kidney so that in addition to genes conserved across species, many human-specific gene features have been identified. Taking advantage of the relatively slow pace of human development, scRNA-seq analysis more precisely identifies the transitional cell states from NPs to nephron formation via S-shaped bodies. scRNA-seq analysis has also been applied to human kidney organoids, allowing precise identification of cell types in the organoids. Comparison of these data with human embryonic kidney data revealed the common or differentially expressed genes in the organoids and showed that the currently available organoids are immature and correspond to the embryonic stage. Thus scRNA-seq has become one of the standard gene expression analyses for renal research.
The weakness of scRNA-seq is the loss of positional information, as dissociation of the tissue into individual cells is required for analysis. Some spatial scRNA-seq techniques, which detect gene expression in histological sections, have been developed and applied to some renal research including kidney injury models. However, current spatial scRNA-seq has not achieved analysis at the single-cell resolution. Instead, new hybridization techniques using a few hundred or thousands of known gene probes have been developed. Further advances in single-cell analysis are expected in the next decade.
Nonmammalian Model Systems for Kidney Development
Organisms separated by millions of years of evolution from humans still provide useful models to study the genetic basis and function of mammalian kidney development. This stems from the fact that all these organisms possess excretory organs designed to remove metabolic wastes from the body and that genetic pathways involved in other aspects of invertebrate development may serve as templates to dissect pathways in mammalian kidney development. The excretory organs of invertebrates differ greatly in their structure and complexity and range in size from a few cells in Caenorhabditis elegans to several hundred cells in Drosophila, to the more recognizable kidneys in amphibians, birds, and mammals. In C. elegans, the excretory system consists of a single large H-shaped excretory cell, a pore cell, a duct cell, and a gland cell. , C. elegans provides many benefits as a model system: the availability of powerful genetic tools including “mutants by mail,” a short life and reproductive cycle, a publicly available genome sequence and resource database ( http://www.wormbase.org ), the ease of performing genetic enhancer-suppressor screens in worms, and the fact that they share many genetic pathways with mammals. Major contributions to our understanding of the function of polycystic and cilia-related genes have been made from studying C. elegans. The Pkd1 and Pkd2 homologs, LOV1 and LOV2 of C. elegans, are involved in cilia development and mating behavior. , Elucidation of the genetic interactions of the Kirrel (Neph1) ortholog and nephrin-like molecules SYG1 and SYG2 in synapse formation in C. elegans also provided clues to the roles of these genes in glomerular and slit diaphragm formation and function in mammals.
Similar to C. elegans, the relative ease of large-scale genetic screens and phenotypic characterization in Drosophila makes it another valuable complementary model for understanding the genetic basis of developmental processes. The excretory system of Drosophila consists of two parts, the nephrocytes and the malpighian tubules, which are functionally analogous to podocytes and renal tubules, respectively. A fundamental difference from vertebrate kidneys is that the nephrocytes and malpighian tubules are not physically connected. Nephrocytes either surround the heart (epicardial nephrocytes) or the esophagus (garland cells) and have elaborate membrane invaginations that closely resemble the glomerular filtration barrier. Remarkably, mutations of Drosophila homologs of genes known to be essential to form slit diaphragms and maintain podocyte functions also impair nephrocyte morphology and filtration functions. Similarly, conserved genes that regulate normal patterning and function of Malpighian tubules and vertebrate renal tubules have been identified. Functional readouts such as impaired nephrocyte filtration or uptake of tracers, ultrastructural analysis, and mortality screens can be executed efficiently in Drosophila, which can facilitate the characterization of novel gene functions that are vital for renal filtration.
The pronephros is the functional kidney of the larva of some fishes (except for jawless fishes, which only develop the pronephros) and amphibians, while the mesonephros serve as the kidney in adults of these aquatic animals. The pronephros of the zebrafish (Danio rerio) larva consists of two tubules connected to a fused, single, midline glomerulus. The zebrafish pronephric glomerulus expresses many of the same genes found in mammalian glomeruli (e.g., Vegfa, Nphs1, Nphs2, and Wt1 ) and contains podocytes and fenestrated endothelial cells. Advantages to the zebrafish as a model system include its short reproductive cycle, transparency of the larvae with easy visualization of defects in pronephric development without sacrificing the organism, the availability of the genome sequence, the ability to rapidly knockout/knockdown gene function, and the ability to perform functional studies of filtration using fluorescently tagged labels of varying sizes. These features make zebrafish amenable to both forward and reverse genetic screens. The pronephros of the clawed frog Xenopus laevis has also been used as a simple model to study early events in nephrogenesis. , Similar to the fish, the pronephros of the clawed frog consists of a single glomus, paired tubules, and a duct. The fact that X. laevis embryos develop rapidly outside the body (all major organ systems are formed by 6 days of age); the ease of injecting DNA, mRNA, and protein; ability to perform grafting; and in vitro culture experiments establish the frog as a valuable model system to dissect early inductive and patterning cues. , The availability of transgenic zebrafish and Xenopus lines that express the fluorescent protein EGFP in pronephric and mesonephric kidneys provides an opportunity to visualize real-time kidney development and function.
Molecular Genetics of Kidney Development in Mammals
Origin of the Kidney: Intermediate Mesoderm Redefined in time And Space
The IM is the origin of anatomically distinct kidney primordia including the pronephros, mesonephros, and metanephros (see Fig. 1.2 ). Therefore a deeper understanding of how the IM forms through body patterning and gives rise to the corresponding kidney primordia along both the temporal and anteroposterior axes is critical. This understanding is also key to the in vitro generation of functional metanephric kidney progenitors from PSCs.
Early insights into IM formation and subsequent Wolffian duct development were gained from studies in nonmammalian vertebrates, taking advantage of the greater feasibility of tissue manipulation techniques. Lineage tracing by direct tissue labeling and transplantation experiments in gastrulation-stage avian embryos revealed that the dorsoventral axis of the trunk is derived from prepatterning along the anteroposterior positioning within the primitive streak. Consequently, the paraxial mesoderm, IM, and lateral plate mesoderm originate from the anterior, middle, and posterior parts of the primitive streak, respectively, and migrate out to form the body trunk ( Fig. 1.10 ).
Developmental origin of metanephric kidney progenitors.
Model for lineage segregation of the ureteric bud (UB) and metanephric mesenchyme (MM). The UB differentiates from E7.5 T- positive primitive streak through the pronephric anlage, a part of anterior intermediate mesoderm (IM) at E8.5. The MM originates from the E7.5 T -positive primitive streak, then stays in the T- positive tail bud mesenchyme until E8.5, and finally differentiates into posterior IM at E9.5. The section image of the E8.5 and E9.5 embryos is shown on the side panels. The magnified image of the tailbud mesenchyme region shows the cell migration from the primitive streak. LPM, Lateral plate mesoderm; PAM, paraxial mesoderm; N, notochord; NT, neural tube; WD, Wolffian duct.
Injection of dye into the c-Pax2/c-Sim1- expressing domain of IM cells adjacent to the 10th somite resulted in labeling of the entire Wolffian duct. This suggests that the Wolffian duct originates from the anteriorly restricted domain of the IM, then proliferates and migrates caudally along the elongation of the body axis. , Another study proposed the involvement of retinoic acid signaling and the downstream Hoxb4 gene in defining the anterior boundary of this Wolffian duct precursor domain, the pronephric anlage, within the IM.
In mice, the IM is first recognized by the Osr1 -positive bilateral stripe domain around E8.5, the 6 to 8 somite stage. Subsequently, genes such as Pax8, Pax2, Lhx1, and Gata3 begin to be expressed in 10 to 12 somite stage embryos in a more restricted domain located adjacent to the 6th to 8th somite level, referred to as the pronephric anlage, which serves as the origin of the Wolffian duct (see Fig. 1.10 ). This Pax2 -expressing cell cluster extends caudally, undergoes a mesenchymal-to-epithelial transition, and finally forms the Wolffian duct by E9.5. Thus along the relative positioning within the embryonic body trunk, the early Osr1 -expressing IM domain at E8.5 can be redefined as the anterior IM (see Fig. 1.10 ). The formed Wolffian duct is characterized by Pax2/Lhx1/Cdh1 expression and now shuts down Osr1 , reaching the urogenital sinus at the caudal end of the trunk.
The initial directed differentiation studies attempting to generate kidney organoids sometimes misidentified this early-stage Osr1+/Pax2+/Lhx1+ IM as the common origin of the entire kidney including the MM. However, at E9.5, adjacent and ventral to the Wolffian duct, there is a cordlike mesenchymal tissue that expresses Osr1+/Wt1+ . This late-stage IM, also called the nephrogenic cord, extends from the presumptive forelimb level (7th–12th somites) to the hindlimb level (23rd–28th somites), giving rise to the future mesonephros and metanephros. In particular, the Hox11 gene family is expressed in the region of the presumptive hindlimb level, presumably determining the future metanephric mesenchyme domain, which is redefined as the posterior IM (see Fig. 1.10 ).
Timing of Differentiation from Brachyury-Expressing (T+) Mesoderm Determines the Anteroposterior Axis in the IM
In vivo lineage tracing experiments using inducible Cre-loxP mouse lines have provided deeper insights into the mechanisms underlying anteroposterior axis formation in the IM. When Osr1 -positive cells at approximately E8.5 to E9.5 were labeled by tamoxifen injection into a dam at E8.5, these cells contributed to all kidney parenchymal cells, namely derivatives of all three metanephric progenitors: NPs, UB, and stromal progenitors. In contrast, Osr1 -positive cells labeled around E9.5 to E10.5 contributed to the nephron and stromal progenitor lineages but not to the UB-derived collecting ducts. In another study, brachyury (T) -expressing nascent mesoderm cells were tracked in light of the mechanisms of embryonic body axis elongation. During gastrulation (E6.5 to E8.5), the caudal T -expressing primitive streak contributes to the formation of anterior (or rostral) trunk structures up to the level of the forelimb, including the heart and foregut-derived endodermal organs. During the following days, T -positive cells continue to self-renew at the caudal end of the embryo, known as the tailbud mesenchyme (or axial progenitor). They continuously differentiate in an additive manner to form the caudal trunk tissues beyond the forelimb level of the embryo, eventually achieving elongation of the body axis. Temporal labeling of T -expressing nascent mesoderm around E7.5 to E8.5 contributed to all three metanephric progenitor lineages. However, T -expressing tail bud mesenchyme labeled around E8.5 to E9.5 contributed only to nephron and stromal progenitors but not to the UB lineage. These results demonstrate that the ureteric bud originates from T+ nascent mesodermal cells around E7.5 and differentiates into T-/Osr1+ early IM, namely the anterior IM, around E8.5. Conversely, the precursors of nephron and stromal progenitors maintain a T+ status until at least E8.5 and transition to T-/Osr1+ late IM around E9.5, corresponding to the posterior IM. Thus the origins of the nephron/stromal progenitors and the ureteric bud are spatially and temporally distinct, and the timing of differentiation from T+ nascent mesoderm determines the anteroposterior axis in the IM.
In summary, the early-onset IM or anterior IM forms the pronephric anlagen at the level of the forelimb and migrates caudally, giving rise to the Wolffian duct, whereas the late-onset IM forms the metanephric mesenchyme via the posterior IM and eventually meets the Wolffian duct, which has migrated from its anterior origin (see Fig. 1.10 ).
Interaction of the Ureteric Bud and Metanephric Mesenchyme
The classic studies with the organ culture system that started in the 1950s , , demonstrated that epithelialization of the MM requires a UB-derived factor. However, the modern era of studies on the early development of the kidney began with the observation of renal agenesis phenotypes in gene-targeted or knockout mice, the earliest among these being the knockout of several transcription factors including Wt1 , Pax2, Eya1, Osr1 (Odd1), Six1, Sall1, Lhx1 (Lim1), and Emx2 . , , The knockout of genes for several secreted signaling molecules such as GDNF (glial cell line–derived neurotrophic factor), GDF11 (growth differentiation factor 11), gremlin, and the receptors Ret and GFRα1 also resulted in renal agenesis, at least in the majority of embryos. These studies revealed that GDNF is the major factor secreted from the MM to attract the Ret-expressing UB toward the MM and that Wnt9b is the UB-derived factor to initiate epithelialization of the NPs in the MM ( Fig. 1.11 ).
Clinical Relevance
Perturbation of cell–cell communication during embryonic kidney development can have wide-ranging detrimental consequences including renal agenesis, CAKUT, proteinuria, kidney cysts, defective urine osmoregulation, acidosis, and predisposition to hypertension and chronic kidney diseases.
Genetic interactions during early metanephric kidney development.
(A) Regulatory interactions control the strategically localized expression of glial cell–derived neurotrophic factor (GDNF) and Ret and the subsequent induction of the ureteric bud. The anterior part of GDNF expression is restricted by Foxc1/2 and Slit2/Robo2 signaling. Spry1 suppresses the postreceptor activity of Ret. BMP4/7-BMPR signaling inhibits the response to GDNF, an effect counteracted by Grem1. The genetic regulatory network controls the expression of (B) GDNF and (C) Ret. BMPR, Bone morphogenetic protein receptor; MM, metanephric mesenchyme; NC, nephrogenic cord; ND, nephric duct; UB, ureteric bud.
Lineage Specification Toward the Metanephric Mesenchyme
Because many of the transcription factors in the MM are required to maintain GDNF expression, their deletion often leads to insufficient UB attraction toward the MM. Two exceptions are the Osr1 (Odd1 )- and Eya1 -mutant embryos, where the MM itself is absent, suggesting that Osr1 and Eya1 represent early determinants of the MM (see Fig. 1.11 ). , Osr1 marks the IM from which the mesenchymal cells within the mesonephros and metanephros are derived and is subsequently downregulated upon epithelial differentiation. Mice lacking Osr1 do not form the MM and do not express several other factors required for metanephric kidney formation including Eya1, Six2, Pax2 , Sall1, or Gdnf .
Eya1 -mediated specification of the MM cell fate is thought to occur via interaction with another transcription factor, Six1 . EYA1 and SIX1 mutations are found in humans with branchiootorenal (BOR) syndrome. Eya1 and Six1 form a regulatory complex that is involved in transcriptional regulation. , Interestingly, Eya1 was shown to have an intrinsic phosphatase activity that regulates the activation of the Eya1/Six1 complex. , Moreover, Eya and Six family genes are coexpressed in several tissues in mammals, Xenopus and Drosophila, further supporting a functional interaction between these genes. , , , , Direct transcriptional targets of this complex appear to include the pro-proliferative factor Myc . In the Eya1 -deficient urogenital ridge the putative MM is completely absent. Consistent with this finding, Six1 is either absent or poorly expressed in the presumptive location of the MM of Eya1 -null embryos. , Eya1 is expressed in the Six1 -null mesenchyme, suggesting that Eya1 is upstream of Six1 . ,
The transcription factor Wt1 is another essential regulator of early MM development. Wt1 expression is weak in the uninduced MM but increases in the condensed cap mesenchyme surrounding the branching UB tips. Wt1 expression remains throughout nephrogenesis but eventually becomes restricted to the presumptive podocytes at the proximal end of the S-shaped nephron. Mature podocytes continue to express Wt1 at high levels. Genetic loss of Wt1 in mice prevents UB outgrowth and causes apoptosis of the MM, whereas human mutations of WT1 have been linked to renal tumors. , Among the numerous identified transcriptional targets of Wt1 known to be required for kidney development are Bmp7, Pax2, and Sall1 . It has also been shown that Wt1 regulates antagonistic fibroblast growth factor (FGF) and bone morphogenetic protein (BMP)/SMAD (contraction of homologous Sma and MAD genes of worms and fruitflies) signaling pathways, effectively promoting the proliferation and survival of the MM. , The absence of Wt1 significantly downregulates the expression of the genes for several FGF ligands, including Fgf8, Fgf10, Fgf16, and Fgf20, which support mesenchymal proliferation. , The impairment of FGF signaling upon loss of Wt1 is exacerbated by the upregulation of BMP/SMAD signaling, which promotes apoptosis. This is thought to occur through the loss of Bmper expression, a direct target of Wt1, which inhibits BMP4 signaling.
At the signaling factor level, compound loss of FGFR1 and FGFR2 in the MM leads to renal agenesis, presumably originating from the misactivation of critical transcription factors such as Six2, Sall1, and Pax2 as early as E10.5.
In Vitro Induction of Nephrons Via Nephron Progenitors
The discovery of the distinct origins of UB and nephron/stromal progenitors has significantly advanced research on the directed differentiation of PSCs ( Fig 1.9 ). The T+ tailbud mesenchyme at E8.5, redefined as the source of NPs, was known to differentiate and be maintained under active Wnt signaling in vivo ( Fig. 1.10 ). Accordingly, T+ tailbud mesenchyme-like cells were induced from mouse ESCs by prolonged exposure to high concentrations of a Wnt signaling agonist (60 hours). The subsequent combined application of activin, retinoic acid, Bmp, and a moderate level of Wnt agonist was found to synergistically induce the expression of Osr1, Wt1, and Hox11, the representative markers of the posterior IM. Subsequent treatment with low levels of Wnt agonists and Fgf9 activated the expression of NP markers. When these NPs were co-cultured with the embryonic spinal cord, acting as exogenous Wnt signaling sources in place of the UB, they differentiated into self-organized epithelial nephron structures that included glomerular podocytes, parietal epithelia (Bowman capsule), and renal tubules. The signaling factors used in mouse ESC differentiation were also effective in inducing human nephron structures from human-induced PSCs (iPSCs), with adjustments made for the interspecies developmental rate. For example, Wnt agonist treatment was extended from 60 hours in mice to 144 hours in humans, corresponding to the approximately 2.5 times longer period of early gastrulation processes. While there are recognizable variations in individual induction protocols, most subsequent reports have adopted sequential induction steps involving prolonged high-Wnt exposure followed by withdrawal of Wnt and addition of FGF signaling to induce the NP lineage , (see Fig. 1.9 ).
Lineage Specification Toward the Nephric Duct/Ureteric Bud
Several components of the genetic network supporting the development of the nephric duct and the UB have been identified (see Fig. 1.11 ). Pax2 and Pax8 are required to maintain the expression of Lhx1 . Nephric duct specification fails in Pax2/Pax8 mutants, while conditional deletion of Lhx1 impairs maintenance of the nephric duct epithelia. Pax2, Pax8, and Lhx1 altogether likely coordinate the expression of Gata3, which is necessary for elongation of the nephric duct. Gata3 and Emx2, which are required for the expression of Ret in the nephric duct, are both regulated by β-catenin (Ctnnb1), an effector of the canonical Wnt signaling pathway. , , Unlike these genes that are expressed in the nephric duct epithelia, Aldh1a2 (Raldh2), a gene in the retinoic acid synthesis pathway, is expressed in the surrounding mesenchyme and likely acts in parallel with Gata3 to maintain Ret expression in the nephric duct epithelia. Therefore the absence of Gata3 or Aldh1a2 causes misguided elongation of the nephric duct, terminating into either blind-ended ureters or abnormal connections between the bladder and urethra. The absence of Aldh1a2 also leads to formation of ectopic ureters and hydronephrotic kidneys. Ret does not affect the nephric duct fate but has importance in later UB development and insertion of the nephric duct to the cloaca. Furthermore, scRNA-seq analysis of the developing nephric duct shows that it is divided into several subdomains from rostral to caudal and Tfap2b is expressed in the midregion. Deletion of Tfap2a and Tfap2b leads to defects in nephric duct morphogenesis and reduction of Gata3 + caudal domains, while Gata3 deletion results in the absence of the Aldh1a3 + Ret + caudalmost domain including the nephric duct tips ( Fig. 1.12 ).
Spatial organization of nephric duct progenitors.
Spatial development of the nephric duct. Representative genes expressed in each region are shown.
Modified with permission from Sanchez-Ferras O, Pacis A, Sotiropoulou M, et al. A coordinated progression of progenitor cell states initiate urinary tract development. Nat Commun. 2021;12:2627.
In Vitro Induction of the Ureteric Bud
The Wolffian duct is derived from the E8.5 anterior IM, which differentiates from the T+ mesoderm earlier than the NP lineage (see Fig. 1.10 ). Consistent with the in vivo lineage separation process, a shorter exposure (36 hours vs. 60 hours in NP induction) of mouse ESCs to high concentrations of Wnt signaling followed by administration of retinoic acid, Fgf, and a transforming growth factor-beta (Tgfb) inhibitor induced the anterior IM to express Osr1/Pax2/Lhx1/Gata3 (see Fig. 1.9 ). The effect of Tgfb inhibitor in inducing anterior IM was in sharp contrast to the requirement of Tgfb superfamily agonist: activin signaling in posterior IM differentiation. Subsequent treatment with a moderate concentration of Wnt agonist, retinoic acid, and Fgf induced committed Wolffian duct precursors expressing Lhx1/Pax2/Ret and exhibiting cell surface molecules Cxcr4+/Kit+. Further continuous treatment with retinoic acid, Wnt signaling, and increased administration of Gdnf signaling induced Wolffian duct maturation and eventual formation of bud structures. Induction of the UB lineage in human iPSCs revealed that a 36-hour Wnt signaling treatment (vs. 144 hours for NP induction) for T+ mesoderm induction and the addition of a Bmp signaling inhibitor to the mouse anterior IM induction factors were critical. These observations suggest a commonly critical feature of the Wnt signal exposure period for the selective induction of either anterior or posterior IM-derived kidney lineages, as well as slight differences in signal requirements between species. Accordingly, subsequent reports on human UB lineage induction commonly used an initial short exposure (24 to 48 hours) of the Wnt signaling for the primitive streak/mesoderm differentiation, and then the anterior IM was induced with the combination of Fgf, retinoic acid, and dual inhibition of Tgfb and Bmp signaling. The induced ureteric buds in both mice and humans show branching capacity in vitro when embedded in the extracellular matrix in the presence of Wnt agonist and Gdnf (see Fig. 1.9 ).
Metanephric Mesenchymal Genes that Induce Ureteric Budding
In many cases of renal agenesis, a failure of the GDNF-Ret signaling axis has been identified. GDNF, a member of the TGF-β superfamily and secreted by the MM, activates the Ret-GFRα1 receptor complex that is expressed by cells of the nephric duct and the UB. Activation of the Ret tyrosine kinase is of central importance to ureteric budding and branching. Most mutant embryos lacking Gdnf, Ret, or Gfra1 exhibit partial or complete renal agenesis due to severe impairment of UB sprouting while exogenous GDNF is sufficient to induce sprouting of ectopic buds from the nephric duct. , , , Consistently, other genes linked to renal agenesis are known to regulate the normal expression of GDNF. These include transcription factors (e.g., Eya1, Pax2, Six1, Hox11 paralogues, and Sall1 ) and proteins required to stimulate or maintain GDNF expression (e.g., GDF11, Kif26b, nephronectin, α8β1-integrin, and Fras1) (see Fig. 1.11 ). , , , ,
As described earlier, Eya1 mutants fail to form the MM. Pax2 is a transcriptional regulator of the paired box family and is expressed widely during the development of both UB and mesenchymal components of the urogenital system. , Through a combination of molecular and in vivo studies, it has been demonstrated that Pax2 appears to act as a transcriptional activator of Gdnf and regulates the expression of Ret . , Pax2 also appears to regulate kidney formation through epigenetic control because it is involved in the assembly of a histone H3–lysine 4 methyltransferase complex through the ubiquitously expressed nuclear factor PTIP, which regulates histone methylation. The Hox genes are conserved in all metazoans and specify positional information along the body axis. Hox11 paralogues include Hoxa11, Hoxc11, and Hoxd11 . Mice carrying mutations in any one of these genes do not have kidney abnormalities; however, triple-mutant mice for these genes demonstrate a complete absence of metanephric kidney induction. Eya1, Pax2, and Hox11 appear to form a complex to coordinately regulate the expression of G dnf . However, the GDNF reduction may not always be mediated by direct transcription. For example, total amount of secreted GDNF can be reduced secondarily when the maintenance of NPs is affected due to the impaired gene regulatory network consisting of multiple transcription factors. Indeed, there are many “super-enhancers,” which are co-occupied by Six2, Hoxd11, Osr1, Wt1, and Sall1, for the genes involved in the progenitor program, and these transcription factors appear to activate one another to maintain the progenitors.
Other possibilities include impaired adhesive interactions within the NPs and between the NP and ureteric bud. For example, Sall1 is necessary for the expression of the kinesin Kif26b by the MM cells, and in the absence of either Sall1 or Kif26b, the α8β1-integrin expressed by the MM is downregulated. The loss of Itga8 (α8 integrin) or Itgb1 (β1-integrin), as well as deletion of their ligand Npnt (nephronectin) expressed in the UB tips, compromises the adhesion of the MM cells to the UB tips, ultimately causing loss of G dnf expression and failure of UB outgrowth. , , A MM-derived secreted protein Isthmin-1 (Ism1) also acts on integrin α8β1 and promotes cell–cell adhesion of the MM, thereby regulating GDNF expression UB attraction. Genetic inactivation of basement membrane proteins associated with Fraser syndrome ( Fras1, Frem1, and Frem2 ) also leads to renal agenesis characterized by severe downregulation of Gdnf expression. , , It has been proposed that the Fras1/Frem1/Frem2 ternary complex anchors nephronectin to the UB basement membrane, thus stabilizing engagement with α8β1 integrin expressed by the MM ( Fig. 1.13 ). Grip1, a PDZ-domain protein known to interact with Fras1, is required to localize the Fras1/Frem1/Frem2 complex on the basal aspect of the UB epithelium. Grip1 mutations phenocopy Fraser syndrome, including renal agenesis, thus further highlighting the importance of the strategic localization of nephronectin on the UB surface toward the opposing MM.
Molecular model of renal defect in Fraser syndrome.
(A) Adhesion to the ureteric bud (UB) epithelium positively regulates the expression of glial cell–derived neurotrophic factor (GDNF) by the metanephric mesenchyme (MM) . Adhesion and GDNF expression are impaired in the absence of (B) nephronectin (expressed by the UB), (C) α8β1 integrin (expressed by the MM), and (D) or the Fras1/Frem1/Frem2 complex. Fras1, Frem1, and Frem2 are implicated in Fraser syndrome and are believed to coordinately anchor nephronectin to the UB basement membrane and stabilize the conjugation with α8β1 integrin.
Modified from Kiyosumi, Takeichi M, Nakano I, et al. Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins. J Cell Biol. 2012;197:677–689.
Ureteric Bud Genes that Regulate Budding and Branching
UB sprouting and subsequent branching requires a unique spatial organization of Ret signaling. The bulbous UB tip is a region enriched with proliferative ureteric epithelial cells, in contrast to the emerging stalk regions of the developing ureteric tree. , It is well appreciated that receptor tyrosine kinase signaling primarily through Ret is key to the proliferation of UB tip epithelia. Exogenous GDNF supplemented in explanted embryonic kidneys can cause expansion of the UB tip region toward the source of the ligand. ERK kinase activation is prominent within the ampullary UB terminals where Ret expression is elevated. Consistently, chimera analysis in mice reveals that Ret-deficient cells do not contribute to the formation of the UB tips. Altogether, these studies underscore the importance of strategic levels of Ret expression and activation of proliferative signaling pathways in the stereotypical sculpting of the nascent collecting duct network.
A ligand-receptor complex formed by GDNF, GFRα1, and Ret is necessary for autophosphorylation of Ret on its intracellular tyrosines ( Fig. 1.14 ). A number of downstream adaptor molecules and effectors have been identified to interact with active phosphorylated Ret, including Grb2, Grb7, Grb10, ShcA, Frs2, PLCγ1, Shp2, Src, and Dok adaptor family members (Dok4/5/6). These downstream Ret effectors altogether are likely contributors to the activation of the Ras/SOS/ERK and PI3K/Akt pathways supporting the proliferation, survival, and migratory behavior of the UB epithelium. , , Knock-in mutations of the interaction site for Shc/Frs2/Dok adaptors on the short isoform of Ret lead to the formation of rudimentary kidneys. , Specific mutation of the PLCγ1 docking site on Ret leads to renal dysplasia and ureter duplications. The loss of Shp2 and upstream ERK regulators Map2k1 (Mek2) and Map2k2 (Mek1) in the UB lineage also cause severe renal hypoplasia phenocopying that is observed in occasional Ret-deficient kidneys. , UB-specific inactivation of Pten , a target of the PI3K/Akt pathway, disrupts UB branching. These findings underscore the significance of Ret signaling in normal UB branching.
Ret signaling pathway.
Ret is activated and becomes autophosphorylated on intracellular tyrosine residues upon association with glial cell–derived neurotrophic factor (GDNF) and GFRα1. Signaling molecules such as Grb2, Shc, FRS2, PLCγ1, and Shp2 bind directly to the phosphorylated tyrosine residues within the intracellular domain of Ret. Recruitment of Shc, FRS2, and Grb2 leads to activation of extracellular signal-regulated kinase (ERK) and PI3K/Akt pathways. GDNF-Ret signaling leads to specific activation of a host of genes, some of which are strongly dependent on the upregulation of the transcription factors Etv4 and Etv5 (solid arrows). Etv4/Etv5 activation requires activation of the PI3K/Akt but not the ERK pathway. Sox8 and Sox9 are believed to act in parallel to reinforce transcriptional responses to GDNF-Ret engagement. Some of these pathways are shared with the FGF7/10-FGFR2 receptor signaling system. Spry1 and Spred2 negatively regulate ERK signaling, whereas Dusp6 likely mitigates the dephosphorylation of the Ret receptor, thus acting as part of a negative feedback regulatory loop.
A number of transcriptional targets of Ret activation in UBs stimulated with GDNF have been elucidated (see Fig. 1.14 ). Among these are Ret itself and Wnt11, which stimulates Gdnf expression in the MM, suggesting that a positive feedback loop exists for the GDNF-Ret signaling pathway. Ret activation also positively regulates the ETS transcription factors Etv4 and Etv5, which are also necessary for normal UB branching morphogenesis. Etv4 -null homozygous mutants and compound heterozygous mutants for Etv4 and Etv5 manifest severe renal hypoplasia or renal agenesis, suggesting that these transcription factors are indispensable targets of Ret for proper UB development. In chimeric animals, Etv4/Etv5 -deficient cells, like Ret -deficient cells, fail to integrate within the UB tip domain. ,
The gene Sprouty was identified as a general antagonist of receptor tyrosine kinases and was discovered for inhibiting the FGF and EGF signaling pathways. Of the four mammalian Sprouty homologs, Spry1 is expressed at the UB tips. Sprouty molecules are thought to uncouple receptor tyrosine kinases with the activation of ERK pathways either through competitive binding with the Grb2/SOS complex or the kinase Raf, effectively repressing ERK activation. Interestingly, its expression is upregulated upon GDNF-mediated Ret activation. This suggests that Ret activates a negative feedback mechanism via Spry1 to control activated ERK levels and modulate cell proliferation in the UB. , Thus Spry1 deficiency leads to ectopic UB induction and it can partially rescue renal development in the absence of either GDNF or Ret. , The transcriptional targets of Ret, such as Etv4, Etv5, and Wnt11, are retained in Gdnf/Spry1 or Ret/Spry1 compound null mutants. , Other signaling including FGF7/FGF10 and FGFR2 receptors is likely to partially compensates the GDNF-Ret pathway.
Negative Regulators of the MM-UB Interaction
A crucial aspect of kidney development that is of great relevance to renal and urologic congenital defects in humans relates to the positioning of the UB (see Fig. 1.11 ). Incorrect positioning of the bud, or duplication of the bud, results in abnormally shaped kidneys and incorrect insertion of the ureter into the bladder, with a resultant ureteral reflux that can predispose to infection and scarring of the kidneys and urologic tract.
Foxc1 is a transcription factor of the Forkhead family, expressed in the IM and the MM adjacent to the Wolffian duct. In the absence of Foxc1, the expression of GDNF adjacent to the Wolffian duct is less restricted than in wild-type embryos. Foxc1 deficiency results in ectopic UBs, hypoplastic kidneys, and duplicated ureters. Additional molecules that regulate the location of UB outgrowth are Slit2 and Robo2, signaling molecules best known for their role in axon repulsion in the developing nervous system. Slit2 is a secreted factor, and Robo2 is its cognate receptor. Slit2 is mainly expressed in the Wolffian duct, whereas Robo2 is expressed in the mesenchyme. UBs form ectopically in embryos deficient in either Slit2 or Robo2, similar to the Foxc1 mutant. However, in contrast to the Foxc1 phenotype, none of the ureters in Slit2/Robo2 mutants failed to undergo the normal remodeling that results in insertion in the bladder. Instead, the ureters remained connected to the nephric duct in Slit2 or Robo2 mutants. The domain of Gdnf expression is expanded anteriorly in the absence of either Slit2 or Robo2 . Indeed, mutations in Robo2 have been identified in patients with vesicoureteral junction defects and vesicoureteral reflux. The absence of Robo2 most likely compromises normal separation of the Wolffian duct from the nephrogenic mesenchyme, ultimately broadening the nephrogenic zone and provoking ectopic UB induction.
Another negative regulator of branching is BMP4, which is expressed in the mesenchyme surrounding the Wolffian duct. Bmp4 heterozygous mutants have duplicated ureters, and, in organ culture, BMP4 blocks the induction of ectopic UBs by GDNF-soaked beads. In contrast, knockout of Grem1, which encodes for the secreted BMP inhibitor gremlin, causes renal agenesis, supporting a role for BMP in the suppression of UB formation.
Maintenance of the Nephron Progenitor Versus Nascent Nephron Formation
The generation of a sufficient number of nephrons requires a highly regulated balance between the expansion of NP compartments and the differentiation toward epithelialized renal vesicles ( Fig. 1.15 ). This has important clinical implications as the impaired renewal of nephron precursors or their perturbed differentiation can ultimately cause a wide range of renal pathologies due to significant paucity of functional nephrons. Here, the extracellular signaling molecules such as Wnt, Bmp, and Fgf, as well as the downstream transcription factor Six2, regulate the delicate balance between progenitor self-renewal and differentiation.
Tripartite inductive interactions regulating ureteric branching, nephron progenitor self-renewal, and nephrogenesis.
Six2 and Cited1 are expressed in the self-renewing nephron progenitors within the cap mesenchyme (CM) surrounding the ureteric bud. The UB tip domains express high levels of Ret, which is activated by glial cell–derived neurotrophic factor (GDNF) from the surrounding CM. Wnt11 is upregulated in response to Ret activation and stimulates GDNF synthesis in the CM. Wnt9b expressed by the UB and Fat4 by the Foxd1-positive stroma are required to initiate nephrogenesis from a subset of the CM. This results in the formation of a transient renal vesicle expressing FGF8 and Wnt4, factors that sustain epithelialization. The stroma expresses Aldh1a2, a gene required for retinoic acid synthesis, and genes for the retinoic acid receptors ( Rara and Rarb ). Retinoic acid signaling stimulates elevated expression of Ret in the UB tip domain while at the same time suppressing Ret expression in the UB cleft domain via Rara/Rarb2 and Ecm1 in the stroma to initiate bifurcation of the UB tip to generate new branches. Foxd1 in the cortical stroma also represses Dcn, thus relieving the Dcn-mediated suppression of BMP7-dependent signaling, which results in phosphorylation of SMAD1/5/8 (pSMAD1/5/8) and epithelialization of the cap mesenchyme.
NPs differentiate into epithelial nephron structures through mesenchymal-to-epithelial transition. The UB-secreted factor Wnt9b activates the canonical β-catenin–dependent pathway and induces the expression of Wnt4 and Fgf8 in part of the cap mesenchyme, called pretubular aggregates. The Wnt4 expressed in pretubular aggregates, in turn, cell-autonomously acts to form epithelialized renal vesicles (see Fig. 1.15 ). Canonical Wnt signaling pathway is necessary and sufficient for the early inductive actions of Wnt9b and Wnt4, although it is also known that Wnt4 can activate a noncanonical alternative pathway during the final phase of epithelialization. ,
Although the Wnt signal was originally recognized as the differentiation-inductive signal in the NPs more recently, its role in the maintenance and proliferation of NPs especially through the interaction with transcription factor Six2, has become apparent in both vivo and in vitro studies.
The transcription factor Six2 is exclusively expressed in the undifferentiated NPs, called cap mesenchyme, which condenses adjacent to the UB and is downregulated once this cap mesenchyme differentiates into pretubular aggregates. Complete loss of Six2 causes premature ectopic formation of renal vesicles and the untimely depletion of nephron precursors. , In contrast, overexpression of Six2 prevented epithelialization of the cap mesenchyme. Therefore Six2 is required to keep these NP cells in a naïve, proliferative precursor state.
At the molecular level, Six2 has been demonstrated to function as both a transcriptional activator that maintains NPs and as part of a repressor complex silencing differentiation-related genes. , For the maintenance of NPs, Six2 synergizes with multiple transcription factors including Osr1, Hoxd11, Wt1, and Sall1 to promote the transcription of relevant downstream genes (e.g., Six2, Eya1, and Sall1 ), forming a positive feedback loop. To prevent nephron differentiation, Six2 interacts with Tcf (Lef) and Aes (Groucho/TLE) to form a repressor complex that suppresses genes related to epithelialization (e.g., Fgf8 and Wnt4 ). ,
The interaction between Wnt signaling pathways and Six2 appears to be intricately dosage, duration, and context dependent. , , , When Six2 expression remains high, Wnt signaling promotes progenitor renewal. In this situation, the stabilization of β-catenin promotes the association of Six2 downstream target Myc with β-catenin, favoring precursor proliferation. , Indeed, deletion of the agonistic Wnt signaling molecules R-spondins ( Rspo1 and Rspo3 ) leads to a rapid decline of NPs in mice. In vitro studies using primary cultures of mouse NPs further indicate the dose-dependent role of Wnt signaling, where weak activation favors proliferation, while strong action drives differentiation.
On the other hand, with a sustained canonical Wnt-signaling pathway, β-catenin accumulates and displaces Groucho family repressors converting the Tcf complex into a differentiation driver. The stabilization of β-catenin eventually interferes with Six2 expression, thus attenuating Six2 expression. Although the continued activation of β-catenin can initiate early tubulogenesis, as evidenced by the expression of Wnt4 and Fgf8, it fails to complete the mesenchymal-to-epithelial transition. Therefore the proper nephron differentiation requires the shutdown of canonical Wnt signaling after a transient activation. The more precise resolution of this time window has been addressed by in vitro nephron differentiation studies using chemical Wnt signaling activators, such as Gsk3β inhibitors. , , ,
Notch signaling is required to prime NPs for differentiation and contributes to the silencing of Six2 expression. All nephron segments fail to form when Notch signaling is lost within the Six2 + precursor lineage.
The growth factor BMP7 is also required for the formation of the nephrogenic compartment. Activation of the Jnk pathway mediates the proliferative effect of BMP7 in uncommitted NPs. , BMP7, through activation of the p38-MAPK, causes upregulation of the transcriptional repressor Trps1 . Loss of Trps1 severely impairs the formation of renal vesicles. It has been speculated that Trps1 may indirectly relieve repression of Cdh1 expression. Additionally, BMP7-dependent phosphorylation and nuclear translocation of SMAD1/5/8 are required for Wnt9b-induced epithelialization. Thus BMP7 has dual essential roles in promoting both progenitor replenishment and priming for epithelialization. How these pathways integrate with Six2 -dependent signaling complexes remains poorly understood.
FGF8, FGF9, and FGF20, and their cognate receptors FGFR1 and FGFR2 are essential to form nephrons. FGF9 and FGF20 are required to maintain the multipotency and proliferative state of NPs. FGF8 is not needed for the NP maintenance or formation of renal vesicles but is required for the survival of the newly formed nephrogenic epithelia. Renal vesicles lacking Fgf8 fail to express Wnt4 and Lhx1 and do not progress into S-shaped intermediate nephrons. , Potential downstream targets of FGFR1/FGFR2 relevant to nephrogenesis are the closely related MAGUK family proteins encoded by the genes Cask and Dlg1 . The absence of Cask and Dlg1 causes impaired proliferation and cell death in nephron precursors, with a distinctive dampening of the Ras/ERK signaling pathway.
On the basis of these observations, the protocols to expand the mouse NPs in vitro have been established and applied to human organoid-derived progenitors. Many of the resumes include BMP, FGF, a Notch inhibitor, and a Wnt activator at low concentrations because too much Wnt stimulation leads to progenitor differentiation. LIF is also shown to be effective for in vitro expansion, but the physiological role of LIF in progenitor maintenance in vivo remains unclear.
Nephron Segmentation and Tubulogenesis
Nephron segments are organized along a proximal–distal axis, from the most proximal renal corpuscle or glomerulus, followed by the proximal tubule, the loop of Henle, the distal tubule, and the most distal connecting tubule that links directly to the UB-derived collecting duct (see Fig. 1.4 ). The segmental patterning of nephrons involves a complex series of events instructed by inductive cues between neighboring cells and controlled by epigenetic signaling mechanisms. A variety of human diseases result from the mispatterning of nephrons.
Elegant imaging studies combined with high-throughput single-cell gene expression analysis demonstrate that nephron patterning is determined as early as the recruitment of mesenchymal NPs from the cap mesenchyme. The renal vesicle arises not from a single event in time. Instead, NPs progressively incorporate into the nascent nephrons, with the timing of their recruitment predicting their acquisition of proximal–distal fates (i.e., initial recruits commit to distal fates while the last recruits contribute to the formation of more proximal fates, including glomerular podocytes) ( Fig. 1.16 ).
Gradual recruitment of progenitor cells during nephrogenesis.
Early recruited nephron progenitors clustering around the ureteric bud give rise to pretubular aggregates. New progenitors continue to be recruited and incorporate into the proximal end of the renal vesicle. Distal, medial, and proximal domains are established by the S-shaped body stage. LOH, Loop of Henle; NPC, nephron progenitor cell; RC, renal corpuscle.
Adapted from Lindström NO, De Sena Brandine G, Tran T, et al. Progressive recruitment of mesenchymal progenitors reveals a time-dependent process of cell fate acquisition in mouse and human nephrogenesis. Dev Cell . 2018;45:651–660.
By the renal vesicle stage, gene expression asymmetry highlights an early establishment of proximal and distal domains. Genes such as Fgf8, Lhx1, Dll1, Dkk1, Hnf1b, Sox9, and Pou3f3 are markedly elevated in the distal portion of the renal vesicles, whereas Wt1, Foxc2, and Mafb are largely restricted in the proximal end. , Some genes are expressed in both regions, such as Wnt4, Jag1, Cdh6, and Ccnd1, albeit nonuniformly and more elevated in the distal domain. By the S-shaped body stage, nephron segmentation has become more evident, with several more marker genes having distinctively regionalized expression patterns.
As the earliest nephron precursors that interact with the UB become destined to acquire distal fates, it can be speculated that localized Wnt9b signaling orients the proximal–distal axis. During nephrogenesis, a gradient of β-catenin activity is established along the longitudinal axis of the nephron as early as the stage of renal vesicle formation, with the highest β-catenin activity found in the distal end and progressively decreasing toward the proximal end. In organ cultures, pharmacologic manipulation of β-catenin activity can alter proximal and distal fate acquisition. Attenuation of β-catenin activity accelerates glomerular development. Conversely, augmentation of β-catenin activity favors the expression of Lgr5, a marker of distal fate, while repressing proximal identity. Indeed, a brief exposure of mouse embryonic or human PSC-derived NPs to a Wnt agonist, combined with subsequent Tgfβ inhibition, results in a biased induction of glomerular podocytes.
After Wnt-mediated mesenchymal-to-epithelial transition, the Notch pathway comes into play, as evidenced by the expression of Notch ligands such as Dll1 and Jag1 in S-shaped bodies. Notch was initially reported to be involved in the proximalization of nephron segments, , but scRNA-seq analysis of mature markers fails to detect a fate bias. This is because Notch promotes proliferation, survival, and maturation of nascent nephron epithelia independent of proximodistal segments, although Notch may support early proximal tubule fate selection.
Although many genes are now known as marking nephron segments, only a few other genes and pathways that strongly influence proximal versus distal fate determination have been characterized. Loss of Hnf1b in the nephrogenic precursors causes marked loss of proximal and median domain markers at the S-shaped body stage, causing the formation of immature and cystic glomeruli connected to the collecting duct by a severely truncated renal tubule. Genes required to generate distal tubules and the loop of Henle are Pou3f3, Sall1, and Adamts1 . ,
Podocyte Development
Presumptive podocytes are located at the proximal end of the S-shaped body, lining the emerging vascular cleft ( Fig. 1.17 ). Immature podocytes are simple columnar epithelia but do not express E-cadherin. Mature podocytes still do not express E-cadherin but atypically express vimentin, an intermediate filament protein more common among mesenchymal cells but weak in most epithelial cells. Therefore podocytes may be in an intermediate state between the mesenchyme and epithelia. The most distinctive morphologic feature of a fully differentiated podocyte is its arborized and stellate appearance. Podocytes ensheathe the glomerular capillaries with their foot processes, effectively forming the final layer of the glomerular filtration barrier. Foot processes emanating from adjacent podocytes interdigitate in trans and form a unique and porous intercellular junction called the slit diaphragm through which primary urinary filtrate passes. Three-dimensional reconstruction of podocyte ultrastructure obtained by block-face scanning electron microscopy reveals the morphologic transformation of podocytes during development and the formation of interdigitating foot processes. , Columnar-shaped immature podocytes are linked by tight and adherens junctions that progressively migrate from the apical to the basal side. Once the junctional complex has descended close to the basement membrane, podocytes begin to flatten, spread, and interdigitate with short primitive foot processes underneath the junctions. As the primitive processes grow, the tight and adherens junctions relocate from the cell body to between the processes forming the immature foot processes. Finally, the junctional complexes are gradually replaced with slit diaphragms, resulting in mature foot processes ( Fig. 1.18 ).
Molecular basis of glomerular development.
Key factors are shown along with the time point where major effects were observed in knockout or transgenic mouse studies. Many factors play roles at more than one time point. Genes identified as mutated in patients with glomerular disease are marked by asterisks.
Structural overview of the slit diaphragm (SD) .
An oversimplified diagram depicting the major adhesion receptors comprising the SD and how they are possibly integrated with the actin cytoskeleton of podocyte foot processes. FP, Podocyte foot process; GBM, glomerular basement membrane.
Adapted from Scott RP, Quaggin SE. Formation and maintenance of a functional glomerulus. In Little MH (ed.). Kidney Development, Disease, Repair and Regeneration. San Diego: Academic Press; 2016.
The transcription factors Wt1, Tcf21, Mafb, Foxc2, and Lmx1b are highly expressed by developing podocytes and are important for the elaboration of podocyte foot processes and the establishment of slit diaphragms. Complete loss of Wt1 leads to renal agenesis. However, specific loss of a Wt1 splice isoform results in poor development of podocyte foot processes. The Wt1 -null phenotype in mice can also be rescued using a yeast artificial chromosome containing the human WT1 gene and, depending on the level of expression of WT1, the mice developed a range of glomerular pathologies ranging from crescentic glomerulonephritis to mesangial sclerosis, clinical features observed in Denys–Drash syndrome arising from a mutant WT1 allele in humans. Podocyte-specific Wt1 deletion in mice results in reduced numbers of mature glomeruli and proximal tubules, as well as increased foot process effacement in the remaining podocytes, leading to death within 1 day of birth. Genome-wide analysis of the Wt1 targets in podocytes reveals that Wt1 autoregulates its own transcription and acts as master regulator of a complex transcriptional network that regulates podocyte development, structure, and function, including transcription factors ( Lmx1b, Tcf21, Mafb, Tead1, Foxc1, and Foxc2 ) and genes strongly linked to podocyte dysfunction and nephrotic diseases ( Actn4, Arhgap24, Cd2ap, Col4a3, Col4a4, Lamb2, Nphs1, Nphs2, and Plce1 ). Among them, Nphs2, MafB, and Magi-2 were significantly downregulated in podocyte-specific Wt1 deletion in mice, indicating that the other transcription factors cannot compensate for the Wt1 loss for expression of these genes. Inactivation of Lmx1b , Tcf21 , Mafb, and Foxc2 causes podocytes to remain as cuboidal epithelia and failure to spread on the glomerular capillary bed. , Tcf21 likely acts upstream of Mafb as the latter is downregulated in Tcf21 -null mice. Loss of Mafb and Lmx1b reduces the expression of Nphs1 (nephrin) and Nphs2 (podocin), the major components of the slit diaphragm of the podocytes, whereas the absence of Foxc2 causes the specific downregulation of Nphs2 and α3α4α5 (IV) collagen. , , Lmx1b mutations are linked to nail-patella syndrome in humans, with a subset of affected individuals manifesting nephrotic disease. , Wt1, Tcf21, Mafb, Foxc2, and Lmx1b are expressed from the S-shape stage onward and remain constitutively expressed in adult glomeruli. Proteinuria develops from loss of these genes, thus underscoring the importance of normal podocyte maturation in the establishment of the glomerular filtration barrier.
Podocytes also produce VEGF-A and other angiogenic growth factors to attract vasculature into glomeruli, as described later in this chapter. It is likely that endothelial cells also produce hitherto unknown trophic factors that promote terminal differentiation and survival of podocytes.
Glomerular Basement Membrane Development
The mature glomerular basement membrane (GBM) is a fusion of the extracellular matrices (ECM) of podocytes and glomerular endothelial cells. The GBM is a highly organized and compositionally complex matrix whose abundant components include collagens (types I, IV, VI, and XVIII); laminins (α5, β2, and γ1); nidogen-1; heparan sulfate proteoglycans (agrin and perlecan); and tubulointerstitial nephritis antigen-like protein. The GBM is an essential part of the glomerular filtration barrier, functioning as an intermediary sieving matrix and a sink for secreted trophic and signaling factors, as well as mediating cellular communication between the glomerular endothelium and podocytes. Furthermore, adhesive cell–ECM interactions among the GBM, podocytes, and glomerular endothelial cells maintain the structural integrity of the glomerular filtration barrier.
Among the major components of the GBM, type IV collagens and laminins have been shown to be the most indispensable, highlighted by proteinuric kidney diseases such as Alport syndrome, Goodpasture disease, and Pierson syndrome. Alport syndrome is linked to a growing list of mutations in the genes COL4A3, COL4A4, and COL4A5 encoding for type IV collagen subunits α3, α4, and α5, respectively. , Maturation of the GBM requires the replacement of juvenile α1α1α2 with α3α4α5 type IV collagen trimers, a developmental switch improving the structural resilience of the GBM. In Alport syndrome, the assembly of heterotrimeric α3α4α5 type IV collagen complex is compromised while the α1α1α2 type IV collagen complexes persist. Because α3α4α5 type IV collagen trimers constitute about half the total proteins in the mature GBM, it is not surprising that Alport syndrome GBM is severely distorted. The importance of type IV collagens in the GBM is further underscored in Goodpasture disease, an autoimmune disorder targeting α3 type IV collagen subunit. In Pierson syndrome, mutations in LAMB2 encoding the laminin β2 subunit impair the assembly of the laminin complex LM-521 (a trimer formed among laminin-α5,-β2, and-γ1 subunits). , Deformation of the GBM and proteinuria results from loss of Lamb2 and Lama5 (laminin-α5) in mice.
Development of the Bowman Capsule
The outermost cells of the proximal end of the S-shaped nascent nephron are the presumptive parietal epithelial cells that eventually form the Bowman capsule, which encloses the glomerular tuft and where primary urinary filtrate collects. Similar to podocytes, parietal precursors are originally cuboidal epithelial cells that progressively flatten and become squamous. Parietal epithelia express the proteins claudin-1 ( Cldn1 ) and claudin-2 ( Cldn2 ) that form part of tight junctions, which help contain urinary filtrate. , Parietal epithelial cells like podocytes express Wt1, although at a reduced level. Whether this differential level of Wt1 expression affects cell fate commitment to either the podocyte or parietal cell lineage warrants further investigation. Specific loss of Cttnb1 (β-catenin) in nephrogenic epithelia from the S-shaped stage causes formation of glomerular cysts, where the Bowman capsule lacks parietal epithelia and is instead formed by podocytes notably containing foot processes and slit diaphragms. Parietal cell specification is therefore strongly dependent on canonical Wnt-β-catenin signaling, which sets it apart from podocytes where Cttnb1 expression is dispensable. In the absence of parietal epithelial cells, glomerular capillaries develop poorly while the mislocalized Vegfa -expressing podocytes cause formation of ectopic capillaries next to the abnormal Bowman capsule. It can therefore be inferred that parietal epithelial cells may function in compartmentalizing the podocyte–glomerular endothelial cell crosstalk, ensuring that glomerular endothelial cells form a well-elaborated capillary tuft covered by an adequate number of podocytes.
Cessation of Nephrogenesis
Nephrogenesis is a time-limited event that is not reactivated post-injury to the kidneys of humans and mice at adulthood. The last wave of nephrogenesis is observed around the 36th week of gestation in humans and shortly after birth in mice. , Cessation of nephron generation is characterized by the exhaustion of NP cells and completion of epithelial differentiation of the remaining nephrogenic precursor. Although various morphologic and molecular changes occurring at this time have been characterized in mouse kidneys, the exact trigger is not fully understood. , , For example, increased oxygen tension after birth could possibly act as an active trigger that ends nephrogenesis, but it may not be a shared mechanism in humans where nephrogenesis ceases before parturition.
In mice, the nephrogenic zone progressively shrivels after birth and is replaced by mature tubules. The NP markers Six2 and Cited1 are significantly downregulated after birth and become undetectable by postnatal day 3 (P3), concomitant with the disappearance of the cap mesenchyme. Multiple newly induced nephrons are found associated with each UB tip at P3 that is no longer found at P7. Ureteric branching also ends between birth and P3 accompanied by a significant reduction of Ret and Wnt11 and loss of the UB ampullary shape. , In contrast, Wnt9b expression in the UB remains high even at P4, which means NP depletion precedes Wnt9b reduction in the UB.
Of course, deletion of mouse genes required for the maintenance of NPs leads to their premature exhaustion before birth. Metabolism also regulates progenitor lifespan. Glycolysis regulates the progenitor state: High glycolytic flux supports self-renewal of young (E13.5) progenitors, whereas inhibition of glycolysis induces their differentiation. Methionine deficiency also results in progenitor depletion. In contrast, reports of mutant mice with delayed arrest are limited. The RNA-binding protein Lin28 inhibits let-7 microRNA expression, thereby regulating developmental timing across species. Transient overexpression of Lin28b or direct reduction of let-7 in mice results in prolonged nephrogenesis, although the precise mechanism remains unknown. Deletion of one copy of Tsc in NPs results in a 25% increase in the number of nephrons. This phenotype is independent of Mtor activity, although Tsc encodes hamartin, an inhibitor of Mtor. Further analysis of these mice suggests that stage-dependent differential translation, but not transcription, of Wnt agonists may tip the balance between FGF9-mediated maintenance and Wnt-mediated differentiation of nephron progenitors. , Specifically, Wnt agonists including R-spondin are poorly translated in young (E14.5) nephron progenitors, while self-renewal promoting FGF20 expression is high, leading to progenitor maintenance. In contrast, in old progenitors (P0), translation of Wnt agonists is increased while FGF20 expression becomes low, leading to differentiation. This tipping point model proposes that when the number of old cells rises above a threshold, all remaining progenitors differentiate en masse. A thorough understanding of the mechanism of cessation of nephrogenesis is necessary to better evaluate the potential of regenerative therapies for the kidney.
Development of the Collecting Duct
The overall shape, structure, and size of the kidneys are largely guided by stereotypical branching of the UB and subsequent patterning of the collecting duct system. During late gestation, past embryonic stage E15.5 in the mouse, the trunks of the UB tree undergo extensive elongation to establish the array of collecting ducts found in the renal medulla and papilla. The radial arrangement of elongated collecting ducts together with the loops of Henle (derived from the NP) establishes the corticomedullary axis by which nephron distributions are patterned. After birth, further elongation of the newly formed collecting duct network is partly responsible for the postnatal growth of the kidney.
Elongation of the collecting duct involves oriented cell division characterized by the parallel alignment of the mitotic spindle of proliferating ductal epithelia with the longitudinal axis of the duct. Oriented cytokinesis therefore guarantees that daughter cells contribute to lengthening of the duct with minimal effect on tubular lumen diameter. The renal medulla and pelvis are nonexistent in mice lacking Wnt7b . Notably, the collecting ducts and loops of Henle are stubbier due to reorientation of cell division toward a radial instead of a longitudinal axis. Wnt7b expression is restricted within the nonbranching stalk of the ureteric tree and is absent in the ampullary UB tips. Failed development of the renal medullary and papillary regions is also recapitulated in mice where Cttnb1 is ablated in the renal stroma, suggesting that Wnt7b activates the canonical β-catenin–dependent Wnt signaling pathway involving the ureteric epithelia and surrounding stroma. However, the relevant reverse signal from the interstitial stroma to the collecting duct that drives oriented cell division in the duct epithelia remains unknown.
Normal development of collecting ducts also depends on cell survival cues provided by diverse ligands, such as Wnt7b, EGF, HGF, and interactions with the extracellular matrix. , , Papillary collecting ducts display higher incidences of apoptosis in mice lacking Wnt7b or EGFR. , Conversely, loss of Dkk1 (Dickkopf1), a secreted antagonist of Wnt7b, results in overgrowth of the renal papilla. The HGF-receptor Met, α3β1 integrin ( Itga3/Itgb1 ), and laminin α5 ( Lama5 ) are all required to maintain expression of Wnt7b and thus likely support the viability of collecting duct cells. , ,
Poor development of the renal medulla and papilla are also observed in mutant mice lacking Fgf7, Fgf10, Fgfr2, Bmpr1a ( Alk3 ) , and Shh (Sonic hedgehog). FGF7 and FGF10 are the cognate ligands of FGFR2. Renal hypoplasia is observed when Fgfr2 is conditionally removed from the ureteric lineage and is more severe than in mutants lacking Fgf7 or Fgf10, suggesting that these related ligands may have some functional redundancy in the development of the UB and collecting ducts. , , Shh is expressed in the more distal derivatives of the UB, the medullary collecting ducts, and the ureter. The germline deletion of Shh results in either bilateral renal agenesis or a single ectopic dysplastic kidney. , It has been shown that Shh controls the expression of early inductive and patterning genes ( Pax2 and Sall1 ), cell cycle regulators ( Mycn and Ccnd1 ), and signaling effectors of the Hedgehog pathway ( Gli1 and Gli2 ). Interestingly, genetic removal of Gli3 in an Shh -null background restores the expression of Pax2, Sall1, Cdnd1 , Mycn , Gli1, and Gli2, providing physiologic proof for the role of Gli3 as a repressor of the Shh pathway in renal development. Frameshift mutations resulting in truncation of the expressed Gli3 protein are linked to Pallister-Hall syndrome and the presence of hydronephrosis and hydroureter in both humans and mice. ,
The mature collecting duct epithelia consist of two major cell subtypes: the abundant principal cells, which strongly express the aquaporins, ion channels, and pumps mediating Na + and K + transport, and the fewer intercalated cells, which are responsible for secretion of protons and bicarbonate ions. UB lineage–specific deletion of mouse Mib1, which encodes an E2 ubiquitin ligase required for initiation of Notch signaling, results in a reduced principal cell/intercalated cell ratio and nephrogenic diabetes insipidus. ADAM10 (a disintegrin and metalloproteinase 10) activates Notch signaling by cleaving Notch ligands, and ureteric bud–specific deletion of this gene in mice also resulted in the reduced principal cell/intercalated cell ratio. Thus Notch signaling regulates the balance of principal and intercalated cells in the developing collecting duct. A model has been proposed in which Notch signaling is important for fate determination at the level of individual cells ( Fig. 1.19 ). The expression of the transcription factor Tfcp2l1 is upregulated in some cell populations during early differentiation, leading to increased expression of intercalated cell-specific genes including the Notch ligand Jag1 . In neighboring cells receiving the Notch signal, Jag1 expression is repressed by negative feedback. On the other hand, negative feedback does not work in the signaling cell, so Jag1 expression is maintained. The propagation of such feedback between neighboring cells determines the activity of Notch signaling at the single-cell level, which ultimately determines the fate of principal and intercalated cells. This model can explain the mosaic distribution of the two cell types. Downstream targets of Notch signaling in the principal cells include the transcription factor Elf5, which positively regulates the expression of the principal cell-specific genes Aqp2 and Avpr2 . Conversely, mice lacking another transcription factor Foxi1 have defects in intercalated cells and are unable to secrete acid in response to acid load leading to metabolic acidosis. Histologic analysis revealed the absence of differentiated principal cells and intercalated cells in these mice, and instead, cells with intermediate characteristics were present in collecting ducts. Such intermediate cells are present in approximately 2% of the collecting ducts of wild-type mice, and these cells are proposed to be immature “collecting duct progenitors.” Indeed, some intercalated cells have been shown to differentiate from AQP2-positive cells. Single-cell RNA sequencing (scRNA-seq) of adult mouse kidneys has also revealed the presence of cells coexpressing both markers, , suggesting plasticity between principal cells and intercalated cells during not only development but also in adult animals. Indeed, genetic activation of Notch is sufficient to drive the transition from interstitial cells to principal cells in adult mice. It remains to be determined whether both genetic changes and environmental cues can influence the plasticity of the two cell types in the collecting duct.



